| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX59 MYO1C MYO7A EIF4A3 PSMC6 MCM5 SMC5 IQCA1L UBA1 ATAD3C SLC27A1 MYO3B DDX23 ASCC3 DNAH6 TOR2A DYNC2H1 BTAF1 RFC3 ATP13A2 ATAD3B DDX20 MYO15A SNRNP200 DDX28 ATP5F1B HELLS | 1.49e-07 | 614 | 278 | 27 | GO:0140657 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 9.12e-07 | 14 | 278 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | IRGM PSG1 PSG3 PSG4 PSG9 CYTH3 TWF2 ATG2A ITPR3 PSG8 ARAP2 VIL1 ATP13A2 GSN NISCH WDFY3 SEPTIN12 | 2.33e-06 | 316 | 278 | 17 | GO:0035091 |
| GeneOntologyMolecularFunction | actin binding | MYO1C PSG1 MYO7A PSG3 PSG4 PSG9 SPTA1 TWF2 NEB ADCY8 SPTBN5 MYO3B PSG8 PLEC VCL VIL1 GSN EGFR PHACTR3 CTNNA1 MYO15A | 3.99e-06 | 479 | 278 | 21 | GO:0003779 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX59 EIF4A3 PSMC6 MCM5 SMC5 IQCA1L ATAD3C DDX23 ASCC3 DNAH6 TOR2A DYNC2H1 BTAF1 RFC3 ATP13A2 ATAD3B DDX20 SNRNP200 DDX28 ATP5F1B | 4.11e-06 | 441 | 278 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | IRGM HBS1L DDX59 LSG1 EIF4A3 PSMC6 MCM5 RRAD SMC5 IQCA1L ATAD3C DDX23 ASCC3 DNAH6 GNL1 EFL1 TOR2A DYNC2H1 DNM1L BTAF1 RFC3 ATP13A2 ATAD3B DDX20 SNRNP200 DDX28 SEPTIN12 ATP5F1B | 4.24e-06 | 775 | 278 | 28 | GO:0017111 |
| GeneOntologyMolecularFunction | calmodulin binding | MYO1C PSG1 MYO7A PSG3 PSG4 PSG9 RRAD ADCY8 PSG8 UBR4 GRIN1 EGFR MYO15A PCNT | 4.51e-06 | 230 | 278 | 14 | GO:0005516 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | IRGM HBS1L DDX59 LSG1 EIF4A3 GARS1 PSMC6 MCM5 RRAD SMC5 IQCA1L ATAD3C DDX23 ASCC3 DNAH6 GNL1 EFL1 TOR2A DYNC2H1 DNM1L BTAF1 RFC3 ATP13A2 ATAD3B DDX20 SNRNP200 DDX28 SEPTIN12 ATP5F1B | 6.64e-06 | 839 | 278 | 29 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | IRGM HBS1L DDX59 LSG1 EIF4A3 GARS1 PSMC6 MCM5 RRAD SMC5 IQCA1L ATAD3C DDX23 ASCC3 DNAH6 GNL1 EFL1 TOR2A DYNC2H1 DNM1L BTAF1 RFC3 ATP13A2 ATAD3B DDX20 SNRNP200 DDX28 SEPTIN12 ATP5F1B | 6.80e-06 | 840 | 278 | 29 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | IRGM HBS1L DDX59 LSG1 EIF4A3 GARS1 PSMC6 MCM5 RRAD SMC5 IQCA1L ATAD3C DDX23 ASCC3 DNAH6 GNL1 EFL1 TOR2A DYNC2H1 DNM1L BTAF1 RFC3 ATP13A2 ATAD3B DDX20 SNRNP200 DDX28 SEPTIN12 ATP5F1B | 6.80e-06 | 840 | 278 | 29 | GO:0016818 |
| GeneOntologyMolecularFunction | helicase activity | DDX59 EIF4A3 MCM5 DDX23 ASCC3 BTAF1 RFC3 DDX20 SNRNP200 DDX28 HELLS | 1.38e-05 | 158 | 278 | 11 | GO:0004386 |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.38e-05 | 23 | 278 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | actin filament binding | MYO1C MYO7A SPTA1 TWF2 NEB SPTBN5 PLEC VCL VIL1 GSN EGFR CTNNA1 MYO15A | 1.90e-05 | 227 | 278 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 4.56e-05 | 29 | 278 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | filamin binding | 4.56e-05 | 29 | 278 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | glycolipid binding | 5.84e-05 | 49 | 278 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | phospholipid binding | IRGM MYO1C SYT12 PSG1 PSG3 PSG4 PSG9 CYTH3 TWF2 ATG2A ITPR3 PSG8 ARAP2 VIL1 ATP13A2 GSN NISCH JCHAIN WDFY3 SEPTIN12 | 9.12e-05 | 548 | 278 | 20 | GO:0005543 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.01e-04 | 34 | 278 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | lipid binding | IRGM MYO1C SYT12 PSG1 PSG3 PSG4 PSG9 CYTH3 TWF2 ATG2A ACOX3 MAP3K1 ITPR3 KL PSG8 FCHSD1 ARAP2 VDR VIL1 BPIFB3 DNM1L PPARD ATP13A2 GSN NISCH JCHAIN WDFY3 IL2 SEPTIN12 | 1.28e-04 | 988 | 278 | 29 | GO:0008289 |
| GeneOntologyMolecularFunction | calcium ion binding | SYT12 SPTA1 FSTL5 FSTL4 ADGRV1 ITPR3 DUOX1 FAT1 SULF1 FER1L5 VIL1 HSPG2 DSC3 CD248 PCDHB6 PCDHB2 PCDHA1 GRIN1 GSN MMRN1 GUCA1A LRP4 AGRN ATP5F1B | 1.38e-04 | 749 | 278 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | EMILIN3 COL21A1 FGB HSPG2 COL6A3 LAMA4 MMRN1 ZP1 COL18A1 AGRN | 3.16e-04 | 188 | 278 | 10 | GO:0005201 |
| GeneOntologyMolecularFunction | kinase activator activity | 3.99e-04 | 159 | 278 | 9 | GO:0019209 | |
| GeneOntologyMolecularFunction | triacylglycerol lipase activity | 4.32e-04 | 26 | 278 | 4 | GO:0004806 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 5.01e-04 | 27 | 278 | 4 | GO:0004709 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 5.35e-04 | 12 | 278 | 3 | GO:0002162 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 5.38e-04 | 73 | 278 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.78e-04 | 28 | 278 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1C PSG1 MYO7A PSG3 PSG4 PSG9 SPTA1 TWF2 ADGRV1 NEB ADCY8 MAP3K1 SPTBN5 MYO3B DLG4 TAOK1 PSG8 PLEC KLC3 VCL VIL1 DNM1L GSN EGFR NISCH PHACTR3 CTNNA1 ARHGEF2 MYO15A | 7.36e-04 | 1099 | 278 | 29 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA helicase activity | 7.66e-04 | 78 | 278 | 6 | GO:0003724 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 7.66e-04 | 78 | 278 | 6 | GO:0043539 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 8.76e-04 | 80 | 278 | 6 | GO:0008186 | |
| GeneOntologyMolecularFunction | kinase binding | CYLD IRGM PSG1 PDGFRB PSG3 PSG4 PSG7 PSG9 DGKQ TWF2 MAP3K1 NBEAL2 DLG4 TAOK1 LRRC7 PSG8 PARP8 DNM1L HDAC7 GSN LIPE EGFR CSPG4 LRP4 PRKAR1B SOCS1 | 1.09e-03 | 969 | 278 | 26 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase activator activity | 1.17e-03 | 149 | 278 | 8 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase regulator activity | IRGM WDR81 DGKQ SLC27A1 TAOK1 GCN1 PARP8 EGFR PRKAR1B SOCS1 MAP2K2 IL2 | 1.24e-03 | 305 | 278 | 12 | GO:0019207 |
| GeneOntologyMolecularFunction | monoacylglycerol lipase activity | 1.31e-03 | 16 | 278 | 3 | GO:0047372 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.57e-03 | 17 | 278 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | structural molecule activity | RPL32 SPTA1 EMILIN3 PSMD11 H3Y1 NEB H3Y2 COL21A1 FGB DLG4 PLEC GNL1 VCL HSPG2 COL6A3 LAMA4 RPSA SRBD1 MMRN1 ZP1 COL18A1 KRT75 CTNNA1 AGRN | 1.61e-03 | 891 | 278 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.62e-03 | 90 | 278 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.69e-03 | 37 | 278 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | GTPase binding | MYO1C MYCBP2 DAPK3 RILP MFF PKN3 VCL RILPL2 DNM1L IPO4 CYFIP2 ARHGEF2 XPOT | 1.69e-03 | 360 | 278 | 13 | GO:0051020 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.87e-03 | 38 | 278 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 1.88e-03 | 5 | 278 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 1.88e-03 | 5 | 278 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.88e-03 | 5 | 278 | 2 | GO:0030156 | |
| GeneOntologyMolecularFunction | small GTPase binding | MYO1C MYCBP2 DAPK3 RILP PKN3 VCL RILPL2 DNM1L IPO4 CYFIP2 ARHGEF2 XPOT | 1.90e-03 | 321 | 278 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | protein kinase binding | CYLD IRGM PSG1 PDGFRB PSG3 PSG4 PSG7 PSG9 TWF2 MAP3K1 NBEAL2 DLG4 TAOK1 LRRC7 PSG8 DNM1L HDAC7 LIPE EGFR CSPG4 LRP4 PRKAR1B SOCS1 | 2.65e-03 | 873 | 278 | 23 | GO:0019901 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.92e-03 | 70 | 278 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.99e-03 | 173 | 278 | 8 | GO:0070851 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SART3 MYCBP2 MYO7A SPTA1 SARM1 FSTL4 DAPK3 MGLL TWF2 LARP4 BRWD3 MAP3K1 BAP1 FAT1 HECW2 NBEAL2 MYO3B DLG4 STRC PLEC DNMBP VCL STRCP1 VDR VIL1 HSPG2 RILPL2 OBSL1 DNM1L GRIN1 WDPCP CYFIP2 COL18A1 LIMK1 EGFR FBXO31 LRP4 ROBO2 ARHGEF2 CFAP44 MAP2K2 AGRN | 5.80e-09 | 1194 | 272 | 42 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.55e-08 | 27 | 272 | 7 | GO:0070344 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.63e-07 | 32 | 272 | 7 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.33e-07 | 49 | 272 | 8 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 2.74e-07 | 50 | 272 | 8 | GO:0002834 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 6.78e-07 | 56 | 272 | 8 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 6.98e-07 | 14 | 272 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 7.14e-07 | 25 | 272 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.04e-06 | 15 | 272 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.04e-06 | 15 | 272 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.04e-06 | 15 | 272 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.04e-06 | 15 | 272 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.49e-06 | 16 | 272 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.09e-06 | 17 | 272 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.09e-06 | 17 | 272 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 2.09e-06 | 17 | 272 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.86e-06 | 18 | 272 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | IRGM PSG1 PSG3 PSG4 PSG9 SPTA1 SARM1 ADGRB2 FSTL4 DAPK3 TWF2 LARP4 BRWD3 MFF PAX8 SULF1 HECW2 DLG4 PSG8 DDHD2 DNMBP VIL1 HSPG2 OBSL1 DNM1L GRIN1 WDPCP LIMK1 AGO1 FBXO31 LRP4 ROBO2 PAX9 MAP2K2 | 2.90e-06 | 1090 | 272 | 34 | GO:0022603 |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.09e-06 | 33 | 272 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 4.28e-06 | 71 | 272 | 8 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | MYO1C SPTA1 TWF2 NEB MAP3K1 SPTBN5 MYO3B FCHSD1 VIL1 GSN CYFIP2 KANK3 | 5.06e-06 | 180 | 272 | 12 | GO:0030832 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 5.07e-06 | 20 | 272 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | SART3 LSG1 EIF4A3 UTP14A AGO3 DDX23 NOPCHAP1 EFL1 GRWD1 RPSA IPO4 DIS3 TBL3 AGO1 UTP25 UTP11 GEMIN4 DDX20 SNRNP200 DDX28 UTP14C | 5.30e-06 | 515 | 272 | 21 | GO:0022613 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 6.58e-06 | 21 | 272 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 6.58e-06 | 21 | 272 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 6.58e-06 | 21 | 272 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 7.17e-06 | 76 | 272 | 8 | GO:0042269 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 8.42e-06 | 22 | 272 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.05e-05 | 80 | 272 | 8 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.06e-05 | 23 | 272 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.06e-05 | 23 | 272 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.13e-05 | 39 | 272 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.33e-05 | 24 | 272 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.33e-05 | 24 | 272 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.33e-05 | 24 | 272 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | DNA alkylation repair | 1.35e-05 | 12 | 272 | 4 | GO:0006307 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.65e-05 | 25 | 272 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.75e-05 | 42 | 272 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.63e-05 | 45 | 272 | 6 | GO:0048521 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.95e-05 | 28 | 272 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | CYLD MYO1C MYCBP2 PDGFRB SPTA1 DAPK3 TWF2 NEB MAP3K1 SPTBN5 MYO3B TAOK1 FCHSD1 VIL1 GSN CYFIP2 LIMK1 KANK3 SENP6 ARHGEF2 AGRN | 3.05e-05 | 579 | 272 | 21 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.52e-05 | 29 | 272 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 3.72e-05 | 95 | 272 | 8 | GO:0070527 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PSG1 PSG3 PSG4 PSG9 FAT1 PSG8 DSC3 PCDHB6 PCDHB2 PCDHA1 ROBO2 | 4.02e-05 | 187 | 272 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell projection assembly | CYLD PDGFRB TWF2 RILP MYO3B DNMBP KLC3 VCL VIL1 RILPL2 DYNC2H1 WDPCP GSN CYFIP2 NPHP3 BBS7 NISCH CSPG4 DNAAF6 CFAP44 AGRN HYDIN PCNT | 4.24e-05 | 685 | 272 | 23 | GO:0030031 |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 4.36e-05 | 156 | 272 | 10 | GO:0030833 | |
| GeneOntologyBiologicalProcess | auditory receptor cell morphogenesis | 4.93e-05 | 31 | 272 | 5 | GO:0002093 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.93e-05 | 31 | 272 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | IRGM PSG1 PDGFRB PSG3 PSG4 PSG9 MAP3K1 MAP3K4 PSG8 EGFR MAP2K2 | 5.36e-05 | 193 | 272 | 11 | GO:0071902 |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 5.46e-05 | 129 | 272 | 9 | GO:0043406 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | MYO1C PDGFRB SPTA1 DAPK3 TWF2 NEB MAP3K1 SPTBN5 MYO3B TAOK1 FCHSD1 VIL1 GSN CYFIP2 LIMK1 KANK3 | 5.53e-05 | 384 | 272 | 16 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | MYO1C SPTA1 FSTL4 MGLL TWF2 RILP NEB MAP3K1 SPTBN5 MYO3B FCHSD1 VIL1 ATP13A2 GSN CYFIP2 LIMK1 KANK3 | 5.54e-05 | 426 | 272 | 17 | GO:0032535 |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 5.78e-05 | 32 | 272 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.78e-05 | 32 | 272 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYCBP2 MYO7A SARM1 FSTL4 MGLL TWF2 HECW2 MYO3B DLG4 STRC VCL STRCP1 HSPG2 OBSL1 DNM1L GRIN1 WDPCP CYFIP2 LIMK1 FBXO31 LRP4 ROBO2 MAP2K2 AGRN | 5.89e-05 | 748 | 272 | 24 | GO:0048667 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO1C PDGFRB MYO7A SPTA1 DAPK3 TWF2 NEB MAP3K1 SPTBN5 FAT1 MYO3B TAOK1 PLEC FCHSD1 VIL1 THSD7A OBSL1 GSN CYFIP2 LIMK1 NISCH KANK3 PHACTR3 ARHGEF2 MYO15A | 6.67e-05 | 803 | 272 | 25 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 6.74e-05 | 33 | 272 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | response to wounding | IL17A PSG1 PSG3 PSG4 PSG9 SARM1 DGKQ ITGA2 MAP3K1 DUOX1 NBEAL2 FGB PSG8 PLEC FER1L5 VCL VIL1 GRIN2C PPARD MMRN1 CTNNA1 MAP2K2 | 6.79e-05 | 659 | 272 | 22 | GO:0009611 |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 6.79e-05 | 53 | 272 | 6 | GO:0034110 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | IRGM PSG1 PDGFRB PSG3 PSG4 PSG9 ADCY8 MAP3K1 MAP3K4 DLG4 PSG8 EGFR SOCS1 MAP2K2 AGRN | 6.89e-05 | 350 | 272 | 15 | GO:0045860 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 7.63e-05 | 105 | 272 | 8 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 7.82e-05 | 34 | 272 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | rescue of stalled ribosome | 7.82e-05 | 34 | 272 | 5 | GO:0072344 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 7.82e-05 | 34 | 272 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CYLD PDGFRB TWF2 RILP MYO3B DNMBP KLC3 VCL VIL1 RILPL2 DYNC2H1 WDPCP GSN NPHP3 BBS7 NISCH CSPG4 DNAAF6 CFAP44 AGRN HYDIN PCNT | 8.63e-05 | 670 | 272 | 22 | GO:0120031 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 9.03e-05 | 35 | 272 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CYLD IRGM PSG1 PSG3 PSG4 PSG9 HLA-DQB1 SPTA1 ITGA2 ADGRV1 IL1RL2 FAT1 ZNF608 FGB DLG4 LRRC7 PSG8 VCL DSC3 PCDHB6 PCDHB2 RPSA PCDHA1 CYFIP2 MMRN1 EGFR SOCS1 ROBO2 CTNNA1 IL2 | 9.41e-05 | 1077 | 272 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 9.93e-05 | 109 | 272 | 8 | GO:0002228 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | CYLD IRGM IL17A MYO1C MYCBP2 SPTA1 ADGRB2 PSMC6 DAPK3 TWF2 ATG2A MAP3K1 SPTBN5 MYO3B DLG4 VCL FCHSD1 VIL1 BIRC2 GRIN1 ATP13A2 WDPCP GSN CYFIP2 LEFTY2 LIMK1 KANK3 SENP6 LRP4 ROBO2 ARHGEF2 AGRN | 1.03e-04 | 1189 | 272 | 32 | GO:0044087 |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | 1.04e-04 | 173 | 272 | 10 | GO:0031333 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 1.26e-04 | 177 | 272 | 10 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.35e-04 | 38 | 272 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.37e-04 | 60 | 272 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.37e-04 | 60 | 272 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.50e-04 | 61 | 272 | 6 | GO:0060259 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PSG1 PDGFRB MYO7A PSG3 PSG4 PSG9 EIF4A3 ITGA2 FAT1 PAX8 SULF1 MYO3B PSG8 STRC STRCP1 VDR HSPG2 ANKH WDPCP SSUH2 LEFTY2 COL18A1 NPHP3 EGFR BBS7 LRP4 PRKAR1B ROBO2 CTNNA1 PAX9 MYO15A MAP2K2 PCNT | 1.52e-04 | 1269 | 272 | 33 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 1.52e-04 | 217 | 272 | 11 | GO:1903034 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | LSG1 EIF4A3 UTP14A EFL1 GRWD1 RPSA IPO4 DIS3 TBL3 UTP25 UTP11 GEMIN4 DDX28 UTP14C | 1.61e-04 | 336 | 272 | 14 | GO:0042254 |
| GeneOntologyBiologicalProcess | cis assembly of pre-catalytic spliceosome | 1.73e-04 | 2 | 272 | 2 | GO:0000354 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 1.73e-04 | 40 | 272 | 5 | GO:0060117 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.73e-04 | 40 | 272 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.76e-04 | 89 | 272 | 7 | GO:1901880 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial fission | 1.79e-04 | 22 | 272 | 4 | GO:0090141 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 1.80e-04 | 9 | 272 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | neutral lipid catabolic process | 1.95e-04 | 41 | 272 | 5 | GO:0046461 | |
| GeneOntologyBiologicalProcess | acylglycerol catabolic process | 1.95e-04 | 41 | 272 | 5 | GO:0046464 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.95e-04 | 41 | 272 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.02e-04 | 91 | 272 | 7 | GO:0051055 | |
| GeneOntologyBiologicalProcess | cell junction assembly | IL17A MYO1C MYCBP2 ADGRB2 DAPK3 ITGA2 DLG4 PLEC VCL PCDHB6 PCDHB2 GRIN1 HDAC7 WDPCP CYFIP2 LRP4 ROBO2 CTNNA1 AGRN | 2.13e-04 | 569 | 272 | 19 | GO:0034329 |
| GeneOntologyBiologicalProcess | cellular component disassembly | IRGM HBS1L SPTA1 SARM1 TWF2 ATG2A SPTBN5 ASCC2 TAOK1 ASCC3 GCN1 VIL1 PNPLA2 GRWD1 DNM1L ATP13A2 GSN ARHGEF2 SAYSD1 PBXIP1 | 2.15e-04 | 617 | 272 | 20 | GO:0022411 |
| GeneOntologyBiologicalProcess | ribosome disassembly | 2.19e-04 | 42 | 272 | 5 | GO:0032790 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MYO1C SPTA1 FSTL4 MGLL TWF2 RILP NEB MAP3K1 SPTBN5 MYO3B FGB FCHSD1 VIL1 PPARD ATP13A2 GSN CYFIP2 LIMK1 EGFR KANK3 | 2.19e-04 | 618 | 272 | 20 | GO:0090066 |
| GeneOntologyBiologicalProcess | actin filament polymerization | 2.24e-04 | 190 | 272 | 10 | GO:0030041 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 2.33e-04 | 66 | 272 | 6 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 2.43e-04 | 124 | 272 | 8 | GO:0001910 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 2.43e-04 | 124 | 272 | 8 | GO:0034109 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | IL17A MYO1C MYCBP2 ADGRB2 DAPK3 DLG4 VCL GRIN1 WDPCP CYFIP2 LRP4 ROBO2 AGRN | 2.50e-04 | 309 | 272 | 13 | GO:1901888 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | MYO1C PDGFRB SPTA1 DAPK3 TWF2 NEB MAP3K1 SPTBN5 MYO3B TAOK1 FCHSD1 VIL1 GSN CYFIP2 LIMK1 KANK3 | 2.51e-04 | 438 | 272 | 16 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 2.53e-04 | 67 | 272 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | platelet activation | 2.56e-04 | 158 | 272 | 9 | GO:0030168 | |
| GeneOntologyCellularComponent | cilium | CYLD PRAMEF7 PSG1 MYO7A PSG3 PSG4 PSG9 ADGRV1 RILP SPTBN5 MYO3B LRRC56 PSG8 STRC DNAH6 KLC3 STRCP1 RILPL2 DYNC2H1 PRAMEF17 PRAMEF8 AK8 WDPCP NPHP3 GUCA1A BBS7 CATSPER4 RNF38 PRKAR1B CFAP44 HYDIN SEPTIN12 PCNT | 1.24e-07 | 898 | 277 | 33 | GO:0005929 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.53e-06 | 16 | 277 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | stereocilium | 3.57e-06 | 69 | 277 | 8 | GO:0032420 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MYO1C MYO7A TWF2 ADGRV1 ITPR3 MYO3B STRC PLEC STRCP1 CA4 VIL1 DNM1L MYO15A | 9.37e-06 | 223 | 277 | 13 | GO:0098862 |
| GeneOntologyCellularComponent | stereocilium bundle | 9.94e-06 | 79 | 277 | 8 | GO:0032421 | |
| GeneOntologyCellularComponent | apical part of cell | PSG1 PDGFRB MYO7A PSG3 PSG4 PSG9 ADCY8 ITPR3 SPTBN5 DUOX1 FAT1 KL PSG8 PLEC SLC4A9 CA4 GP2 DYNC2H1 WDPCP EGFR CSPG4 | 4.54e-05 | 592 | 277 | 21 | GO:0045177 |
| GeneOntologyCellularComponent | actin cytoskeleton | DENND2A MYO1C MYO7A SPTA1 DAPK3 TWF2 NEB ADCY8 MAP3K1 SPTBN5 MYO3B LRRC7 VCL FCHSD1 VIL1 GSN CTNNA1 ARHGEF2 MYO15A SEPTIN12 | 9.23e-05 | 576 | 277 | 20 | GO:0015629 |
| GeneOntologyCellularComponent | apical plasma membrane | PSG1 PDGFRB MYO7A PSG3 PSG4 PSG9 ADCY8 ITPR3 DUOX1 FAT1 KL PSG8 PLEC CA4 GP2 WDPCP EGFR CSPG4 | 9.55e-05 | 487 | 277 | 18 | GO:0016324 |
| GeneOntologyCellularComponent | basal part of cell | MYO1C PSG1 PSG3 PSG4 PSG9 ITGA2 ADCY8 SLC27A1 DLG4 LRRC7 PSG8 PLEC SLC4A9 CA4 EGFR | 1.70e-04 | 378 | 277 | 15 | GO:0045178 |
| GeneOntologyCellularComponent | cell surface | IL17A PSG1 PDGFRB PSG3 PSG4 PSG7 PSG9 SARM1 ITGA2 ADGRV1 DUOX1 SULF1 FGB PSG8 STRC STRCP1 CA4 GP2 CD248 RAET1G GRIN1 BTN3A1 EGFR CSPG4 LRP4 ULBP2 ROBO2 RAET1L AGRN ATP5F1B | 1.78e-04 | 1111 | 277 | 30 | GO:0009986 |
| GeneOntologyCellularComponent | basal plasma membrane | MYO1C PSG1 PSG3 PSG4 PSG9 ADCY8 SLC27A1 DLG4 LRRC7 PSG8 PLEC SLC4A9 CA4 EGFR | 2.89e-04 | 354 | 277 | 14 | GO:0009925 |
| GeneOntologyCellularComponent | cell-cell junction | PSG1 PSG3 PSG4 PSG9 CYTH3 FNDC1 FAT1 UBA1 DLG4 LRRC7 PSG8 DNMBP VCL DSC3 OBSL1 GSN CTNNA1 ARHGEF2 MAP2K2 | 3.64e-04 | 591 | 277 | 19 | GO:0005911 |
| GeneOntologyCellularComponent | cell leading edge | MYO1C PDGFRB CYTH3 TWF2 ADGRV1 DUOX1 FAT1 DAGLA VIL1 GRIN1 GSN LIMK1 EGFR CSPG4 ROBO2 CTNNA1 ARHGEF2 | 3.94e-04 | 500 | 277 | 17 | GO:0031252 |
| GeneOntologyCellularComponent | activating signal cointegrator 1 complex | 5.20e-04 | 3 | 277 | 2 | GO:0099053 | |
| GeneOntologyCellularComponent | adherens junction | 5.55e-04 | 212 | 277 | 10 | GO:0005912 | |
| GeneOntologyCellularComponent | secretory vesicle | PRAMEF7 SYT12 GARS1 FSTL4 GPR84 PSMD11 DCST2 MFF ITPR3 NBEAL2 FGB EXOC3L1 DLG4 LRRC7 FER1L5 VCL CA4 GP2 UBR4 DNM1L GRIN1 PRAMEF17 PRAMEF8 STK31 GSN MMRN1 LEFTY2 ATAD3B CATSPER4 CTNNA1 FRMPD3 | 5.65e-04 | 1246 | 277 | 31 | GO:0099503 |
| GeneOntologyCellularComponent | anchoring junction | PSG1 PDGFRB PSG3 PSG4 PSG9 CYTH3 ITGA2 FNDC1 FAT1 UBA1 DLG4 LRRC7 PSG8 PLEC DNMBP VCL HSPG2 DSC3 OBSL1 GSN LIMK1 EGFR CSPG4 CTNNA1 ARHGEF2 MAP2K2 | 5.95e-04 | 976 | 277 | 26 | GO:0070161 |
| GeneOntologyCellularComponent | cell projection membrane | MYO1C PSG1 PSG3 PSG4 PSG9 ADGRV1 PSG8 DAGLA CA4 GRIN1 EGFR BBS7 CSPG4 ROBO2 ARHGEF2 | 6.77e-04 | 431 | 277 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | membrane raft | MYO1C DAPK3 ADCY8 SULF1 SLC27A1 VCL GP2 VDR LIPE EGFR LRP4 CTNNA1 ATP5F1B | 1.15e-03 | 362 | 277 | 13 | GO:0045121 |
| GeneOntologyCellularComponent | main axon | 1.19e-03 | 89 | 277 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | membrane microdomain | MYO1C DAPK3 ADCY8 SULF1 SLC27A1 VCL GP2 VDR LIPE EGFR LRP4 CTNNA1 ATP5F1B | 1.21e-03 | 364 | 277 | 13 | GO:0098857 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.26e-03 | 90 | 277 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | actin-based cell projection | MYO1C MYO7A TWF2 ADGRV1 FAT1 MYO3B LRRC7 STRC STRCP1 VIL1 MYO15A | 1.27e-03 | 278 | 277 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | cytosolic ribosome | 1.34e-03 | 124 | 277 | 7 | GO:0022626 | |
| GeneOntologyCellularComponent | side of membrane | CYLD IL17A PSG1 PSG3 PSG4 PSG9 HLA-DQB1 SPTA1 ITGA2 ITPR3 FGB DLG4 PSG8 ALG6 CA4 GP2 CD248 RAET1G BIRC2 BTN3A1 ULBP2 RAET1L MAP2K2 | 1.46e-03 | 875 | 277 | 23 | GO:0098552 |
| GeneOntologyCellularComponent | ciliary membrane | 1.95e-03 | 98 | 277 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | receptor complex | PSG1 PDGFRB PSG3 PSG4 PSG9 GPR84 ITGA2 ADGRV1 ITPR3 DLG4 PSG8 VDR BIRC2 GRIN1 GRIN2C EGFR IFNL3 | 2.03e-03 | 581 | 277 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | secretory granule | PRAMEF7 GARS1 FSTL4 GPR84 PSMD11 DCST2 ITPR3 NBEAL2 FGB EXOC3L1 LRRC7 VCL CA4 GP2 UBR4 PRAMEF17 PRAMEF8 STK31 GSN MMRN1 LEFTY2 ATAD3B CATSPER4 CTNNA1 FRMPD3 | 2.20e-03 | 1014 | 277 | 25 | GO:0030141 |
| MousePheno | abnormal muscle triglyceride level | 1.07e-07 | 36 | 233 | 8 | MP:0031412 | |
| MousePheno | decreased carbon dioxide production | 6.11e-07 | 31 | 233 | 7 | MP:0008964 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 6.48e-06 | 17 | 233 | 5 | MP:0031047 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.04e-05 | 31 | 233 | 6 | MP:0031413 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.16e-05 | 47 | 233 | 7 | MP:0031617 | |
| MousePheno | abnormal hair cell physiology | 1.55e-05 | 49 | 233 | 7 | MP:0003879 | |
| MousePheno | increased skeletal muscle triglyceride level | 2.02e-05 | 21 | 233 | 5 | MP:0031415 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 2.18e-05 | 35 | 233 | 6 | MP:0031618 | |
| MousePheno | decreased fatty acid oxidation | 4.04e-05 | 24 | 233 | 5 | MP:0014172 | |
| MousePheno | decreased muscle cell glucose uptake | 4.14e-05 | 39 | 233 | 6 | MP:0030022 | |
| MousePheno | abnormal cochlear hair cell physiology | 4.80e-05 | 40 | 233 | 6 | MP:0004432 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 5.95e-05 | 60 | 233 | 7 | MP:0009790 | |
| MousePheno | increased abdominal fat pad weight | 7.37e-05 | 27 | 233 | 5 | MP:0009286 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 8.35e-05 | 44 | 233 | 6 | MP:0031023 | |
| MousePheno | failure of neuromuscular synapse postsynaptic differentiation | 8.81e-05 | 6 | 233 | 3 | MP:0001055 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 8.85e-05 | 28 | 233 | 5 | MP:0020950 | |
| MousePheno | abnormal wound healing | PSG1 PDGFRB PSG3 PSG4 PSG9 MAP3K1 NBEAL2 PSG8 PLEC VIL1 PPARD GSN | 9.58e-05 | 193 | 233 | 12 | MP:0005023 |
| MousePheno | abnormal carbon dioxide production | 1.21e-04 | 67 | 233 | 7 | MP:0008962 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.21e-04 | 67 | 233 | 7 | MP:0004130 | |
| MousePheno | abnormal fibroblast migration | 1.37e-04 | 48 | 233 | 6 | MP:0011706 | |
| MousePheno | abnormal middle ear morphology | 1.48e-04 | 92 | 233 | 8 | MP:0000049 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.54e-04 | 49 | 233 | 6 | MP:0020948 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 1.79e-04 | 120 | 233 | 9 | MP:0009786 | |
| MousePheno | abnormal sensory neuron physiology | 1.92e-04 | 72 | 233 | 7 | MP:0010055 | |
| MousePheno | abnormal large intestine morphology | CYLD PRAMEF7 PSG1 PSG3 PSG4 PSG9 BAP1 PSG8 VDR PRAMEF17 PRAMEF8 LEFTY2 EGFR IL2 | 2.23e-04 | 276 | 233 | 14 | MP:0000489 |
| MousePheno | abnormal colon morphology | 2.32e-04 | 152 | 233 | 10 | MP:0000495 | |
| MousePheno | duplex kidney | 2.39e-04 | 19 | 233 | 4 | MP:0004017 | |
| MousePheno | decreased cellular glucose uptake | 2.40e-04 | 53 | 233 | 6 | MP:0003926 | |
| MousePheno | thick neurocranium | 2.41e-04 | 8 | 233 | 3 | MP:0030278 | |
| MousePheno | absent cochlear hair bundle ankle links | 2.77e-04 | 2 | 233 | 2 | MP:0004582 | |
| MousePheno | abnormal cochlear hair bundle ankle links morphology | 2.77e-04 | 2 | 233 | 2 | MP:0004581 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 2.89e-04 | 186 | 233 | 11 | MP:0020912 | |
| MousePheno | decreased oxygen consumption | 3.42e-04 | 79 | 233 | 7 | MP:0005290 | |
| MousePheno | abnormal cochlear hair cell inter-stereocilial links morphology | 3.57e-04 | 9 | 233 | 3 | MP:0004577 | |
| MousePheno | impaired fibroblast cell migration | 3.57e-04 | 9 | 233 | 3 | MP:0011707 | |
| MousePheno | abnormal circulating triglyceride level | PSG1 PDGFRB PSG3 PSG4 PSG9 CYTH3 GARS1 MGLL PSPH NDUFS1 PSG8 FTO PNPLA2 USP24 PPARD COL18A1 LIPE LPCAT3 NISCH HELLS | 4.08e-04 | 516 | 233 | 20 | MP:0011969 |
| MousePheno | atelectasis | 4.44e-04 | 108 | 233 | 8 | MP:0001177 | |
| MousePheno | decreased fibroblast cell migration | 4.47e-04 | 39 | 233 | 5 | MP:0011708 | |
| MousePheno | abnormal somatic nervous system physiology | 4.63e-04 | 83 | 233 | 7 | MP:0005423 | |
| MousePheno | abnormal circulating lipid level | IRGM HBS1L PSG1 PDGFRB PSG3 PSG4 PSG9 CYTH3 GARS1 MGLL PSPH SMC5 NDUFS1 MAP3K1 ATAD3C KCNK3 DLG4 PSG8 TAF2 FTO DOP1B VIL1 COL6A3 PNPLA2 RILPL2 USP24 PCDHB6 PPARD COL18A1 ATAD3B NPHP3 LIPE ACTR6 LPCAT3 NISCH CSPG4 GEMIN4 HELLS | 4.70e-04 | 1305 | 233 | 38 | MP:0003949 |
| MousePheno | abnormal basement membrane morphology | 5.04e-04 | 40 | 233 | 5 | MP:0004272 | |
| MousePheno | hearing/vestibular/ear phenotype | PRAMEF7 MYO1C MYO7A TMCO6 ADGRV1 PSPH DPP8 ERLEC1 ADCY9 MAP3K1 SPTBN5 KL PAX8 MYO3B STRC DNMBP STRCP1 VDR HSPG2 GRIN1 PRAMEF17 PRAMEF8 ANKH WDPCP RNF123 EGFR NISCH PAX9 MYO15A | 5.33e-04 | 905 | 233 | 29 | MP:0005377 |
| MousePheno | absent distortion product otoacoustic emissions | 5.66e-04 | 41 | 233 | 5 | MP:0004737 | |
| MousePheno | abnormal lipid metabolism | 5.74e-04 | 86 | 233 | 7 | MP:0013245 | |
| MousePheno | increased incidence of tumors by chemical induction | 5.92e-04 | 141 | 233 | 9 | MP:0004499 | |
| Domain | - | IRGM HBS1L DDX59 MYO7A LSG1 EIF4A3 PSMC6 MCM5 RRAD SMC5 ATAD3C DDX23 DLG4 ASCC3 DNAH6 GNL1 CHST3 EFL1 TOR2A DYNC2H1 DNM1L BTAF1 RFC3 AK8 ATAD3B NPHP3 UTP25 DDX20 MYO15A SNRNP200 HYDIN DDX28 SEPTIN12 ATP5F1B HELLS | 1.27e-09 | 746 | 274 | 35 | 3.40.50.300 |
| Domain | P-loop_NTPase | IRGM HBS1L DDX59 MYO1C MYO7A LSG1 EIF4A3 PSMC6 MCM5 RRAD SMC5 ATAD3C MYO3B DDX23 DLG4 ASCC3 DNAH6 GNL1 CHST3 EFL1 TOR2A DYNC2H1 DNM1L BTAF1 RFC3 AK8 ATAD3B NPHP3 UTP25 DDX20 MYO15A SNRNP200 HYDIN DDX28 SEPTIN12 ATP5F1B HELLS | 2.95e-09 | 848 | 274 | 37 | IPR027417 |
| Domain | ConA-like_dom | ADGRV1 MEP1A FAT1 COL21A1 NBEAL2 HSPG2 LAMA4 BTN3A1 MMRN1 COL18A1 RNF123 CSPG4 WDFY3 AGRN | 4.61e-06 | 219 | 274 | 14 | IPR013320 |
| Domain | Ig_2 | 1.14e-05 | 73 | 274 | 8 | PF13895 | |
| Domain | Quino_amine_DH_bsu | 1.41e-05 | 22 | 274 | 5 | IPR011044 | |
| Domain | Laminin_G | 2.15e-05 | 58 | 274 | 7 | IPR001791 | |
| Domain | ig | PSG1 PDGFRB PSG3 PSG4 PSG7 PSG9 FSTL5 FSTL4 IL1RL2 PSG8 HSPG2 OBSL1 | 2.50e-05 | 190 | 274 | 12 | PF00047 |
| Domain | Immunoglobulin | PSG1 PDGFRB PSG3 PSG4 PSG7 PSG9 FSTL5 FSTL4 IL1RL2 PSG8 HSPG2 OBSL1 | 2.50e-05 | 190 | 274 | 12 | IPR013151 |
| Domain | Helicase_C | 2.82e-05 | 107 | 274 | 9 | PF00271 | |
| Domain | HELICc | 2.82e-05 | 107 | 274 | 9 | SM00490 | |
| Domain | Helicase_C | 3.04e-05 | 108 | 274 | 9 | IPR001650 | |
| Domain | DEXDc | 3.27e-05 | 109 | 274 | 9 | SM00487 | |
| Domain | HELICASE_CTER | 3.27e-05 | 109 | 274 | 9 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.27e-05 | 109 | 274 | 9 | PS51192 | |
| Domain | Helicase_ATP-bd | 3.52e-05 | 110 | 274 | 9 | IPR014001 | |
| Domain | LamG | 4.17e-05 | 44 | 274 | 6 | SM00282 | |
| Domain | ARM-type_fold | SARM1 TMCO6 MAP3K1 NBEAL2 AP1G2 TAF2 GCN1 PPP4R1 UBR4 USP24 BTAF1 IPO4 RIF1 AOPEP WDFY3 XPOT | 4.39e-05 | 339 | 274 | 16 | IPR016024 |
| Domain | AAA+_ATPase | PSMC6 ATAD3C ASCC3 DNAH6 TOR2A DYNC2H1 RFC3 ATAD3B SNRNP200 ATP5F1B | 5.36e-05 | 144 | 274 | 10 | IPR003593 |
| Domain | AAA | PSMC6 ATAD3C ASCC3 DNAH6 TOR2A DYNC2H1 RFC3 ATAD3B SNRNP200 ATP5F1B | 5.36e-05 | 144 | 274 | 10 | SM00382 |
| Domain | - | 7.82e-05 | 95 | 274 | 8 | 2.60.120.200 | |
| Domain | DEAD/DEAH_box_helicase_dom | 9.66e-05 | 73 | 274 | 7 | IPR011545 | |
| Domain | DEAD | 9.66e-05 | 73 | 274 | 7 | PF00270 | |
| Domain | IGc2 | PSG1 PDGFRB PSG3 PSG4 PSG7 PSG9 FSTL5 FSTL4 PSG8 HSPG2 OBSL1 ROBO2 | 1.92e-04 | 235 | 274 | 12 | SM00408 |
| Domain | Ig_sub2 | PSG1 PDGFRB PSG3 PSG4 PSG7 PSG9 FSTL5 FSTL4 PSG8 HSPG2 OBSL1 ROBO2 | 1.92e-04 | 235 | 274 | 12 | IPR003598 |
| Domain | Q_MOTIF | 1.94e-04 | 37 | 274 | 5 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 1.94e-04 | 37 | 274 | 5 | IPR014014 | |
| Domain | - | 2.14e-04 | 2 | 274 | 2 | 3.30.420.140 | |
| Domain | SSU_processome_Utp14 | 2.14e-04 | 2 | 274 | 2 | IPR006709 | |
| Domain | YqgF/RNaseH-like_dom | 2.14e-04 | 2 | 274 | 2 | IPR006641 | |
| Domain | Utp14 | 2.14e-04 | 2 | 274 | 2 | PF04615 | |
| Domain | - | 2.14e-04 | 2 | 274 | 2 | 1.10.3500.10 | |
| Domain | YqgFc | 2.14e-04 | 2 | 274 | 2 | SM00732 | |
| Domain | Tex-like_dom | 2.14e-04 | 2 | 274 | 2 | IPR023323 | |
| Domain | LAM_G_DOMAIN | 2.21e-04 | 38 | 274 | 5 | PS50025 | |
| Domain | BEACH | 2.46e-04 | 9 | 274 | 3 | PS50197 | |
| Domain | Beach | 2.46e-04 | 9 | 274 | 3 | SM01026 | |
| Domain | BEACH_dom | 2.46e-04 | 9 | 274 | 3 | IPR000409 | |
| Domain | Beach | 2.46e-04 | 9 | 274 | 3 | PF02138 | |
| Domain | - | 2.46e-04 | 9 | 274 | 3 | 1.10.1540.10 | |
| Domain | Laminin_G_1 | 4.72e-04 | 11 | 274 | 3 | PF00054 | |
| Domain | DUF3523 | 6.37e-04 | 3 | 274 | 2 | IPR021911 | |
| Domain | RILP | 6.37e-04 | 3 | 274 | 2 | PF11461 | |
| Domain | - | 6.37e-04 | 3 | 274 | 2 | 1.10.150.310 | |
| Domain | Tex_RuvX-like_dom | 6.37e-04 | 3 | 274 | 2 | IPR023097 | |
| Domain | RILP | 6.37e-04 | 3 | 274 | 2 | IPR021563 | |
| Domain | DUF3523 | 6.37e-04 | 3 | 274 | 2 | PF12037 | |
| Domain | DEAD_ATP_HELICASE | 1.04e-03 | 31 | 274 | 4 | PS00039 | |
| Domain | Sec63 | 1.26e-03 | 4 | 274 | 2 | PF02889 | |
| Domain | Sec63 | 1.26e-03 | 4 | 274 | 2 | SM00973 | |
| Domain | Sec63-dom | 1.26e-03 | 4 | 274 | 2 | IPR004179 | |
| Domain | VINCULIN_1 | 1.26e-03 | 4 | 274 | 2 | PS00663 | |
| Domain | Argonaute_N | 1.26e-03 | 4 | 274 | 2 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 1.26e-03 | 4 | 274 | 2 | IPR032473 | |
| Domain | ArgoL2 | 1.26e-03 | 4 | 274 | 2 | IPR032472 | |
| Domain | Lipase_GDXG_HIS_AS | 1.26e-03 | 4 | 274 | 2 | IPR002168 | |
| Domain | Lipase_GDXG_put_SER_AS | 1.26e-03 | 4 | 274 | 2 | IPR033140 | |
| Domain | Vinculin_CS | 1.26e-03 | 4 | 274 | 2 | IPR000633 | |
| Domain | ArgoN | 1.26e-03 | 4 | 274 | 2 | PF16486 | |
| Domain | ArgoMid | 1.26e-03 | 4 | 274 | 2 | PF16487 | |
| Domain | ArgoL2 | 1.26e-03 | 4 | 274 | 2 | PF16488 | |
| Domain | RNA-helicase_DEAD-box_CS | 1.33e-03 | 33 | 274 | 4 | IPR000629 | |
| Domain | - | FSTL5 FSTL4 WDR81 BRWD3 NBEAL2 GRWD1 TBL3 WDPCP THOC6 NBAS BBS7 WDFY3 CFAP44 | 1.34e-03 | 333 | 274 | 13 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | FSTL5 FSTL4 WDR81 BRWD3 NBEAL2 GRWD1 TBL3 WDPCP THOC6 NBAS BBS7 WDFY3 CFAP44 | 1.41e-03 | 335 | 274 | 13 | IPR015943 |
| Domain | - | 1.68e-03 | 222 | 274 | 10 | 1.25.10.10 | |
| Domain | EGF-like_CS | ZNRF4 MEP1A FAT1 GP2 HSPG2 CD248 LAMA4 ADAM22 MMRN1 LRP4 AGRN | 1.71e-03 | 261 | 274 | 11 | IPR013032 |
| Domain | HEAT_type_2 | 1.82e-03 | 17 | 274 | 3 | IPR021133 | |
| Domain | - | PSG1 MYCBP2 PDGFRB PSG3 PSG4 PSG7 PSG9 HLA-DQB1 FSTL5 FSTL4 IL1RL2 FNDC1 RIMBP3C PSG8 HSPG2 COL6A3 OBSL1 BTN3A1 ROBO2 RIMBP3B | 1.93e-03 | 663 | 274 | 20 | 2.60.40.10 |
| Domain | Vinculin | 2.08e-03 | 5 | 274 | 2 | PF01044 | |
| Domain | DUF4704 | 2.08e-03 | 5 | 274 | 2 | IPR031570 | |
| Domain | DUF4704 | 2.08e-03 | 5 | 274 | 2 | PF15787 | |
| Domain | RH2 | 2.08e-03 | 5 | 274 | 2 | PS51777 | |
| Domain | RH1 | 2.08e-03 | 5 | 274 | 2 | PS51776 | |
| Domain | DUF1785 | 2.08e-03 | 5 | 274 | 2 | SM01163 | |
| Domain | ARM-like | SARM1 TMCO6 NBEAL2 AP1G2 GCN1 PPP4R1 BTAF1 IPO4 RIF1 WDFY3 XPOT | 2.22e-03 | 270 | 274 | 11 | IPR011989 |
| Domain | MYOSIN_MOTOR | 2.26e-03 | 38 | 274 | 4 | PS51456 | |
| Domain | MHC_I/II-like_Ag-recog | 2.26e-03 | 38 | 274 | 4 | IPR011162 | |
| Domain | Myosin_head_motor_dom | 2.26e-03 | 38 | 274 | 4 | IPR001609 | |
| Domain | Myosin_head | 2.26e-03 | 38 | 274 | 4 | PF00063 | |
| Domain | MYSc | 2.26e-03 | 38 | 274 | 4 | SM00242 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | PDGFRB SPTA1 PSMC6 PSMD11 SPTBN5 KL AGO3 FGB DLG4 LRRC7 VCL RCE1 GRIN1 AGO1 EGFR MAP2K2 IL2 | 1.05e-05 | 327 | 214 | 17 | M27565 |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA | 1.84e-05 | 55 | 214 | 7 | M41823 | |
| Pubmed | HBS1L RPL32 MYO1C MYCBP2 PDGFRB LSG1 EIF4A3 HLA-DQB1 PSMC6 MCM5 PSMD11 LARP4 ACOX3 ITPR3 AGO3 NBEAL2 SLC27A1 CHPF2 NCEH1 ASCC3 ALG6 GCN1 RCE1 UBR4 DNM1L RPSA IPO4 PARP14 DIS3 COG8 CYFIP2 NBAS LPCAT3 NISCH GEMIN4 DDX20 ATP5F1B PCNT | 2.71e-13 | 1168 | 279 | 38 | 19946888 | |
| Pubmed | SART3 MYO1C MYCBP2 UTP14A MCM5 LARP4 NDUFS1 ITPR3 SUPT6H DDX23 PLEC ASCC3 GCN1 VCL UBR4 USP24 RPSA IPO4 DIS3 TBL3 RIF1 UTP25 GEMIN4 DDX20 CTNNA1 SNRNP200 XPOT PCNT | 7.65e-13 | 653 | 279 | 28 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 MYO7A CYTH3 ADGRB2 KDM3B DGKQ MCM5 TMCO6 ATG2A ADCY9 ACOX3 BAP1 ITPR3 FAT1 NBEAL2 LRRC56 AP1G2 PLEC DNMBP GCN1 PKN3 HSPG2 PNPLA2 UBR4 RPSA BTAF1 ATP13A2 HDAC7 NISCH KANK3 CSPG4 LRP4 WDFY3 ARHGEF2 AGRN PCNT | 1.17e-12 | 1105 | 279 | 36 | 35748872 |
| Pubmed | SART3 EIF4A3 PSMC6 MCM5 PSMD11 NDUFS1 UBA1 SUPT6H PLEC ASCC3 GCN1 GRWD1 UBR4 USP24 DNM1L RPSA IPO4 DIS3 TBL3 RIF1 GEMIN4 DDX20 MAP2K2 SNRNP200 ATP5F1B XPOT HELLS | 2.72e-12 | 638 | 279 | 27 | 33239621 | |
| Pubmed | CYLD MYCBP2 KDM3B ADGRV1 SMC5 ADCY9 BAP1 ZNF608 GCN1 DAGLA DOP1B THSD7A OBSL1 DIS3 WDFY3 SNRNP200 PCNT | 4.78e-12 | 225 | 279 | 17 | 12168954 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 HBS1L MYO1C MYCBP2 LSG1 EIF4A3 GARS1 UTP14A PSMC6 MCM5 PSMD11 LARP4 NDUFS1 NDUFS3 UBA1 DDX23 AP1G2 TAF2 PLEC ASCC3 GCN1 VCL DSC3 UBR4 RPSA SRBD1 IPO4 RFC3 DIS3 TBL3 RIF1 GEMIN4 DDX20 WDFY3 ARHGEF2 AGRN SNRNP200 ATP5F1B XPOT | 5.25e-12 | 1353 | 279 | 39 | 29467282 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF7 ZNF143 NET1 WDR81 LARP4 NDUFS1 IQCA1L TAOK1 PLEC MOCS1 HSPG2 COL6A3 PRAMEF17 PRAMEF8 DIS3 GSN LPCAT3 HERC4 SENP7 XPOT | 2.01e-11 | 363 | 279 | 20 | 14691545 |
| Pubmed | SART3 DENND2A EIF4A3 KDM5C KDM3B ATG2A ADGRV1 ADCY9 BAP1 ZNF608 SULF1 SUPT6H HECW2 NBEAL2 FTO DNMBP DAGLA ANKH DIS3 SENP6 LRP4 ROBO2 HERC4 | 7.10e-11 | 529 | 279 | 23 | 14621295 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 HBS1L RPL32 DDX59 LSG1 EIF4A3 GARS1 UTP14A MCM5 LARP4 INTS3 NDUFS3 UBA1 SUPT6H DDX23 PLEC GCN1 GNL1 PTPMT1 GRWD1 UBR4 USP24 RPSA RFC3 DIS3 GSN RIF1 ISOC2 KRT75 EGFR GEMIN4 DDX20 CTNNA1 ARHGEF2 SNRNP200 ATP5F1B XPOT HELLS | 7.89e-11 | 1415 | 279 | 38 | 28515276 |
| Pubmed | CYLD SART3 RPL32 MYCBP2 LSG1 UTP14A NDUFS1 NDUFS3 ADCY9 ITPR3 SUPT6H ASCC2 DDX23 DDHD2 ASCC3 VCL PTPMT1 GRWD1 DSC3 DYNC2H1 ST7 UBR4 OBSL1 IPO4 TARS2 TBL3 NBAS COL18A1 ATAD3B EGFR BBS7 NISCH PRKAR1B CTNNA1 SNRNP200 PBXIP1 ATP5F1B PCNT HELLS | 8.63e-11 | 1487 | 279 | 39 | 33957083 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | SART3 EIF4A3 KDM5C MCM5 HECW2 GCN1 PKN3 UBR4 BIRC2 IPO4 NPHP3 GEMIN4 DDX20 ARHGEF2 SNRNP200 PBXIP1 DDX28 XPOT | 1.04e-10 | 313 | 279 | 18 | 38270169 |
| Pubmed | CYLD MYCBP2 LSG1 CYTH3 ADGRB2 WDR81 DAPK3 UBA1 AGO3 DLG4 LRRC7 TAF4 UBR4 PAK5 DNM1L GRIN1 IPO4 ADAM22 GSN CYFIP2 AGO1 NISCH OTUD4 PRKAR1B CTNNA1 WDFY3 FRMPD3 ARHGEF2 AGRN PCNT | 2.97e-10 | 963 | 279 | 30 | 28671696 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPL32 MYO1C MYCBP2 LSG1 LRRC49 GARS1 SARM1 UTP14A PSMC6 DAPK3 PSMD11 LARP4 NDUFS1 NDUFS3 ADCY9 MFF ITPR3 SPTBN5 DDHD2 GNL1 PTPMT1 ST7 UBR4 OBSL1 BIRC2 DNM1L TARS2 TBL3 NBAS ATAD3B UTP11 NISCH GEMIN4 DDX20 ARHGEF2 DDX28 ATP5F1B PCNT | 3.81e-10 | 1496 | 279 | 38 | 32877691 |
| Pubmed | SART3 DENND2A RPL32 MYO1C MYO7A SPTA1 LRRC49 DAPK3 TWF2 ITGA2 NDUFS1 NDUFS3 UBA1 ATAD3C HECW2 SLC27A1 DLG4 LRRC7 PLEC DNAH6 DAGLA VCL DNM1L RPSA GRIN1 ADAM22 GSN CYFIP2 ATAD3B AGO1 NISCH OTUD4 CTNNA1 ARHGEF2 SNRNP200 PBXIP1 ATP5F1B | 4.10e-10 | 1431 | 279 | 37 | 37142655 | |
| Pubmed | CYLD SART3 KDM3B PSMC6 PSMD11 ITPR3 UBA1 ASCC2 PLEC ASCC3 HSPG2 UBR4 USP24 TBL3 RNF123 FBXO31 OTUD4 ARHGEF2 HERC4 AGRN PCNT | 4.55e-10 | 481 | 279 | 21 | 28190767 | |
| Pubmed | ZNF143 MYO7A KDM3B NEB INTS3 NDUFS1 ITPR3 TAF2 FER1L5 DYNC2H1 UBR4 USP24 STK31 TBL3 RNF123 ATAD3B ADAMTS6 BBS7 PHACTR3 OTUD4 WDFY3 ARHGEF2 MAP2K2 HELLS | 5.05e-10 | 638 | 279 | 24 | 31182584 | |
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 7.19e-10 | 14 | 279 | 6 | 26196244 | |
| Pubmed | CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. | 1.19e-09 | 15 | 279 | 6 | 15467833 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 HBS1L RPL32 MYO1C PDGFRB LSG1 EIF4A3 GARS1 UTP14A PSMC6 MCM5 PSMD11 NDUFS1 NDUFS3 UBA1 SUPT6H GCN1 VCL GRWD1 DYNC2H1 UBR4 DNM1L RPSA IPO4 RFC3 TARS2 DIS3 TBL3 CYFIP2 RIF1 GEMIN4 DDX20 SNRNP200 ATP5F1B XPOT HELLS | 1.34e-09 | 1425 | 279 | 36 | 30948266 |
| Pubmed | MYO1C LARP4 NDUFS1 NDUFS3 TAF4 UBR4 DNM1L RFC3 TARS2 DIS3 TBL3 ATAD3B EGFR ARHGEF2 MAP2K2 XPOT HELLS | 1.34e-09 | 323 | 279 | 17 | 24797263 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HBS1L RPL32 EIF4A3 GARS1 UTP14A KDM3B PSMC6 MCM5 INTS3 NDUFS1 NDUFS3 BAP1 DDX23 TAOK1 TAF4 PLEC ASCC3 GCN1 GRWD1 UBR4 USP24 DNM1L RPSA IPO4 DIS3 TBL3 COL18A1 DDX20 ARHGEF2 MAP2K2 AGRN SNRNP200 ATP5F1B XPOT | 2.38e-09 | 1318 | 279 | 34 | 30463901 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EIF4A3 PSMC6 MCM5 PSMD11 INTS3 DDX23 TAOK1 PLEC GCN1 USP24 DNM1L BTAF1 RFC3 SSUH2 RIF1 GEMIN4 CTNNA1 ARHGEF2 MAP2K2 SNRNP200 PCNT HELLS | 2.50e-09 | 582 | 279 | 22 | 20467437 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SARM1 PSMC6 PSMD11 ERLEC1 NDUFS3 ITPR3 CHPF2 ASCC3 GCN1 PTPMT1 DYNC2H1 UBR4 USP24 OBSL1 BTAF1 IPO4 RFC3 TARS2 TBL3 COG8 ATAD3B NISCH GEMIN4 DDX20 CTNNA1 ARHGEF2 XPOT HELLS | 3.38e-09 | 942 | 279 | 28 | 31073040 |
| Pubmed | SART3 MYO1C EIF4A3 GARS1 PSMC6 PSMD11 INTS3 NDUFS1 ITPR3 PLEC GCN1 GNL1 VIL1 UBR4 RPSA IPO4 RFC3 PARP14 TBL3 ATAD3B CTNNA1 MAP2K2 SNRNP200 ATP5F1B | 4.23e-09 | 711 | 279 | 24 | 33022573 | |
| Pubmed | SART3 HBS1L RPL32 NET1 LSG1 UTP14A PSMC6 MCM5 NDUFS1 NDUFS3 MFF SUPT6H ASCC2 TAF2 TAF4 ASCC3 DNMBP RCE1 GRWD1 RPSA SRBD1 IPO4 TBL3 CYFIP2 COL18A1 RIF1 UTP25 GEMIN4 OTUD4 ULBP2 DDX20 ARHGEF2 AGRN PBXIP1 DDX28 ATP5F1B | 4.86e-09 | 1497 | 279 | 36 | 31527615 | |
| Pubmed | MYO1C EIF4A3 MCM5 PSMD11 LARP4 UBA1 DDX23 TAF4 PLEC GRWD1 UBR4 RPSA SRBD1 DIS3 RIF1 GEMIN4 OTUD4 DDX20 ARHGEF2 SNRNP200 ATP5F1B | 5.06e-09 | 551 | 279 | 21 | 34728620 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CYLD MYCBP2 LSG1 UTP14A PSMC6 SMC5 LARP4 UBA1 AGO3 ASCC2 TAF2 PLEC ASCC3 DNMBP GCN1 VCL RPSA GSN CYFIP2 THOC6 ATAD3B AGO1 OTUD4 HELLS | 6.00e-09 | 724 | 279 | 24 | 36232890 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | IRGM RPL32 ZNF143 MYO1C PDGFRB GARS1 MCM5 PSPH NDUFS1 NDUFS3 FAT1 ATAD3C TAOK1 NCEH1 PLEC DNAH6 MOCS1 HSPG2 PTPMT1 CD248 TOR2A RPSA TARS2 DIS3 CYFIP2 ATAD3B EGFR LPCAT3 CSPG4 OXNAD1 CFAP44 AGRN SNRNP200 PBXIP1 ATP5F1B | 7.53e-09 | 1451 | 279 | 35 | 30550785 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART3 RPL32 ZNF143 NET1 MYCBP2 MYO7A GARS1 PSMC6 DPP8 NDUFS1 UBA1 PLEC NOPCHAP1 GCN1 PKN3 KLC3 VCL CHST3 RCE1 DYNC2H1 OBSL1 IPO4 HDAC7 DIS3 GSN RIF1 NPHP3 BBS7 LPCAT3 NISCH DDX20 CTNNA1 SNRNP200 | 9.10e-09 | 1321 | 279 | 33 | 27173435 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPL32 MYO1C MYCBP2 EIF4A3 HLA-DQB1 GARS1 PSMC6 MCM5 PSMD11 NDUFS1 NDUFS3 UBA1 DDX23 ASCC3 GCN1 PTPMT1 UBR4 RPSA BTAF1 IPO4 RFC3 TARS2 DIS3 TBL3 RIF1 ATAD3B GEMIN4 DDX20 SNRNP200 ATP5F1B XPOT HELLS | 1.00e-08 | 1257 | 279 | 32 | 37317656 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYO1C ITPR3 PLEC ASCC3 GCN1 RPSA BTAF1 IPO4 PARP14 NBAS EGFR ARHGEF2 SNRNP200 | 1.13e-08 | 202 | 279 | 13 | 33005030 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SART3 HBS1L DDX59 MYCBP2 LSG1 MCM5 LARP4 MAP3K4 ITPR3 SUPT6H ASCC2 ASCC3 RFC3 TBL3 UTP25 ACTR6 NISCH ARHGEF2 | 2.23e-08 | 440 | 279 | 18 | 34244565 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | EIF4A3 EMILIN3 MCM5 INTS3 PLEC GCN1 HSPG2 RPSA CTNNA1 AGRN SNRNP200 ATP5F1B HELLS | 2.95e-08 | 219 | 279 | 13 | 31353912 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART3 RPL32 MYO1C LSG1 EIF4A3 GARS1 UTP14A DAPK3 MCM5 ITPR3 UBA1 ASCC2 PLEC ASCC3 GRWD1 DSC3 RPSA SRBD1 IPO4 RFC3 TBL3 GSN THOC6 ATAD3B EGFR UTP11 GEMIN4 CTNNA1 ARHGEF2 SNRNP200 ATP5F1B | 3.55e-08 | 1257 | 279 | 31 | 36526897 |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 3.91e-08 | 13 | 279 | 5 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 3.91e-08 | 13 | 279 | 5 | 19273835 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 20044046 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 32150576 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 3.91e-08 | 13 | 279 | 5 | 12832451 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 25406283 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 8380065 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 1279194 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 25724769 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 3.91e-08 | 13 | 279 | 5 | 22092845 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 3.91e-08 | 13 | 279 | 5 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 3.91e-08 | 13 | 279 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 3.91e-08 | 13 | 279 | 5 | 23800882 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 3.91e-08 | 13 | 279 | 5 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 3.91e-08 | 13 | 279 | 5 | 39168268 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 8402684 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 3.91e-08 | 13 | 279 | 5 | 21949477 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 26219866 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 2133556 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 3.91e-08 | 13 | 279 | 5 | 19358828 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 3.91e-08 | 13 | 279 | 5 | 34058224 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 3.91e-08 | 13 | 279 | 5 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 3.91e-08 | 13 | 279 | 5 | 25972571 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 3.91e-08 | 13 | 279 | 5 | 15220458 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 18843289 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 15207636 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 21081647 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 11133662 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 11483763 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 18003729 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 3.91e-08 | 13 | 279 | 5 | 27695943 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 3.91e-08 | 13 | 279 | 5 | 16638824 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 3.91e-08 | 13 | 279 | 5 | 21670291 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 22162753 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 2702644 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 11801635 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 21760897 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 1719235 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 16619040 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 3.91e-08 | 13 | 279 | 5 | 8209741 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 32521208 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 3.91e-08 | 13 | 279 | 5 | 29967450 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 1653760 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 32169849 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 3.91e-08 | 13 | 279 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 3.91e-08 | 13 | 279 | 5 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 3.91e-08 | 13 | 279 | 5 | 15316023 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 15331748 | ||
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 3.91e-08 | 13 | 279 | 5 | 22406619 | |
| Pubmed | 3.91e-08 | 13 | 279 | 5 | 7628460 | ||
| Interaction | CIT interactions | CYLD HBS1L RPL32 MYO1C EIF4A3 UTP14A PSMC6 DAPK3 MCM5 ADGRV1 NDUFS3 MAP3K4 ITPR3 UBA1 ATAD3C PAX8 SUPT6H HECW2 DDX23 DLG4 PLEC GCN1 GRWD1 DSC3 DYNC2H1 UBR4 OBSL1 RPSA GRIN1 SRBD1 RFC3 TBL3 GSN NBAS RIF1 ATAD3B DDX20 CTNNA1 ARHGEF2 SNRNP200 DDX28 ATP5F1B XPOT UTP14C | 3.38e-07 | 1450 | 272 | 44 | int:CIT |
| Interaction | YWHAZ interactions | CYLD MYCBP2 SPTA1 RRAD DPP8 NEB SMC5 MFF MAP3K1 MAP3K4 BAP1 UBA1 NBEAL2 KCNK3 DLG4 MAP3K15 PLEC DNMBP KLC3 VCL ARAP2 DSC3 PARP8 PAK5 OBSL1 DNM1L HDAC7 ADAM22 GSN CYFIP2 LIMK1 EGFR NISCH OTUD4 PLEKHM3 WDFY3 ARHGEF2 MAP2K2 SENP7 ATP5F1B PCNT | 4.86e-07 | 1319 | 272 | 41 | int:YWHAZ |
| Interaction | STIP1 interactions | SART3 DDX59 EIF4A3 PSMC6 MCM5 PSMD11 NEB NDUFS1 BAP1 UBA1 SUPT6H PLEC ASCC3 GCN1 GRWD1 UBR4 USP24 DNM1L RPSA IPO4 DIS3 TBL3 RIF1 RNF123 EGFR GEMIN4 OTUD4 DDX20 CTNNA1 MAP2K2 SNRNP200 ATP5F1B XPOT HELLS | 8.16e-07 | 1006 | 272 | 34 | int:STIP1 |
| Interaction | SIRT7 interactions | SART3 MYO1C MYCBP2 UTP14A MCM5 LARP4 NDUFS1 ITPR3 SUPT6H DDX23 PLEC ASCC3 GCN1 VCL UBR4 USP24 RPSA IPO4 DIS3 TBL3 RIF1 UTP25 GEMIN4 DDX20 CTNNA1 SNRNP200 XPOT PCNT | 1.06e-06 | 744 | 272 | 28 | int:SIRT7 |
| Interaction | TOP3B interactions | MYO1C MYCBP2 MYO7A CYTH3 ADGRB2 KDM3B DGKQ MCM5 TMCO6 ATG2A LARP4 ADCY9 ACOX3 BAP1 ITPR3 FAT1 NBEAL2 LRRC56 AP1G2 PLEC DNMBP GCN1 PKN3 HSPG2 PNPLA2 GRWD1 UBR4 RPSA BTAF1 IPO4 ATP13A2 HDAC7 NISCH KANK3 CSPG4 OTUD4 LRP4 DDX20 WDFY3 ARHGEF2 AGRN DDX28 PCNT | 1.25e-06 | 1470 | 272 | 43 | int:TOP3B |
| Interaction | CDC5L interactions | CYLD EIF4A3 UTP14A PSMC6 MCM5 PSMD11 SMC5 INTS3 ERLEC1 BAP1 DDX23 PLEC GCN1 GRWD1 USP24 OBSL1 DNM1L BTAF1 RFC3 SSUH2 RIF1 FOXP4 EGFR GEMIN4 SENP6 CTNNA1 ARHGEF2 SNRNP200 PCNT HELLS | 1.80e-06 | 855 | 272 | 30 | int:CDC5L |
| Interaction | PSG4 interactions | 2.18e-06 | 8 | 272 | 4 | int:PSG4 | |
| Interaction | EEF1AKMT3 interactions | KDM5C WDR81 INTS3 UBA1 NBEAL2 ASCC2 AP1G2 ASCC3 DNMBP GCN1 PARP14 DIS3 FOXP4 RNF123 GEMIN4 ARHGEF2 MAP2K2 HELLS | 2.49e-06 | 364 | 272 | 18 | int:EEF1AKMT3 |
| Interaction | SNW1 interactions | EIF4A3 PSMC6 PSMD11 SMC5 INTS3 UBA1 HECW2 ASCC2 DDX23 TAOK1 PLEC GCN1 VDR OBSL1 DNM1L BTAF1 RFC3 RIF1 EGFR JCHAIN GEMIN4 PRKAR1B ARHGEF2 MAP2K2 SNRNP200 ATP5F1B HELLS | 3.54e-06 | 747 | 272 | 27 | int:SNW1 |
| Interaction | SPTAN1 interactions | CYLD MYO1C MYCBP2 EIF4A3 MCM5 BAP1 SPTBN5 AGO3 PLEC DNAH6 VCL PPP4R1 GRWD1 PAK5 GRIN1 CYFIP2 EGFR RNF38 CTNNA1 AGRN PCNT | 4.22e-06 | 496 | 272 | 21 | int:SPTAN1 |
| Interaction | LRRC31 interactions | MYO1C ITPR3 PLEC ASCC3 GCN1 RPSA BTAF1 IPO4 PARP14 NBAS EGFR ARHGEF2 SNRNP200 | 4.55e-06 | 205 | 272 | 13 | int:LRRC31 |
| Interaction | ARRDC2 interactions | 7.78e-06 | 54 | 272 | 7 | int:ARRDC2 | |
| Interaction | UBC interactions | CYLD SART3 PSMC6 PSMD11 ITPR3 UBA1 ASCC2 PLEC ASCC3 UBR4 USP24 TBL3 GSN RNF123 FBXO31 OTUD4 ARHGEF2 HERC4 PCNT | 1.12e-05 | 446 | 272 | 19 | int:UBC |
| Interaction | EFTUD2 interactions | CYLD SART3 HBS1L RPL32 DDX59 LSG1 EIF4A3 GARS1 UTP14A MCM5 SMC5 LARP4 INTS3 NDUFS3 BAP1 UBA1 DDX23 PLEC GCN1 GNL1 EFL1 PTPMT1 GRWD1 UBR4 USP24 OBSL1 RPSA RFC3 DIS3 THOC6 RIF1 ISOC2 EGFR SOCS1 DDX20 CTNNA1 ARHGEF2 SNRNP200 ATP5F1B HELLS | 1.22e-05 | 1449 | 272 | 40 | int:EFTUD2 |
| Interaction | WDR5 interactions | CYLD SART3 ZBTB48 MYO1C EIF4A3 GARS1 PSMC6 PSMD11 INTS3 NDUFS1 BAP1 ITPR3 ZNF608 TAF4 PLEC GCN1 GNL1 VIL1 GRWD1 UBR4 DNM1L RPSA IPO4 RFC3 PARP14 TBL3 ATAD3B CTNNA1 ARHGEF2 MAP2K2 SNRNP200 ATP5F1B HELLS | 1.51e-05 | 1101 | 272 | 33 | int:WDR5 |
| Interaction | FBXW7 interactions | CYLD SART3 DDX59 MYO1C MYCBP2 EIF4A3 UTP14A PSMD11 MFF MEP1A SUPT6H DDX23 TAOK1 PLEC ASCC3 GCN1 MOCS1 HSPG2 PTPMT1 UBR4 DNM1L SRBD1 IPO4 HDAC7 DIS3 EGFR UTP11 OTUD4 DDX20 ARHGEF2 SNRNP200 SENP7 ATP5F1B XPOT HELLS | 1.89e-05 | 1215 | 272 | 35 | int:FBXW7 |
| Interaction | GAN interactions | SPTA1 SPTBN5 UBA1 PLEC DNAH6 COL6A3 DYNC2H1 PAK5 RPSA PARP14 KRT75 CFAP44 PCNT | 4.26e-05 | 253 | 272 | 13 | int:GAN |
| Interaction | SIRT6 interactions | SART3 HBS1L DDX59 MYCBP2 LSG1 PSMC6 MCM5 LARP4 MAP3K4 ITPR3 FAT1 SUPT6H ASCC2 ASCC3 TROAP RFC3 TBL3 UTP25 ACTR6 NISCH ARHGEF2 SNRNP200 | 4.69e-05 | 628 | 272 | 22 | int:SIRT6 |
| Interaction | UBR4 interactions | CYLD SART3 MYCBP2 PDGFRB FSTL4 PSMC6 BAP1 GNL1 GRWD1 UBR4 BIRC2 RNF123 EGFR HERC4 SNRNP200 | 5.26e-05 | 334 | 272 | 15 | int:UBR4 |
| Interaction | NR3C1 interactions | ZNF143 MYO7A KDM3B MCM5 NEB INTS3 NDUFS1 BAP1 ITPR3 TAF2 FER1L5 VIL1 DYNC2H1 UBR4 USP24 STK31 TBL3 RNF123 ATAD3B EGFR ADAMTS6 BBS7 PHACTR3 OTUD4 WDFY3 ARHGEF2 MAP2K2 ATP5F1B HELLS | 5.79e-05 | 974 | 272 | 29 | int:NR3C1 |
| Interaction | KRT18 interactions | LRRC49 GARS1 PSMC6 MCM5 SMC5 BAP1 ITPR3 UBA1 PLEC SYCE1 EFL1 OBSL1 KRT75 EGFR BBS7 CTNNA1 PCNT | 5.99e-05 | 419 | 272 | 17 | int:KRT18 |
| Interaction | PSG1 interactions | 6.19e-05 | 51 | 272 | 6 | int:PSG1 | |
| Interaction | KIF23 interactions | RPL32 MYO1C EIF4A3 GARS1 UTP14A PSMC6 SMC5 LARP4 NDUFS3 MAP3K4 ITPR3 ATAD3C AGO3 DDX23 PLEC GCN1 GRWD1 OBSL1 TBL3 GSN LIMK1 ATAD3B EGFR GEMIN4 OTUD4 OXNAD1 DDX20 ARHGEF2 SNRNP200 ATP5F1B | 6.51e-05 | 1031 | 272 | 30 | int:KIF23 |
| Interaction | TPTE interactions | 6.51e-05 | 129 | 272 | 9 | int:TPTE | |
| Interaction | NR2C2 interactions | HBS1L RPL32 EIF4A3 GARS1 UTP14A KDM3B PSMC6 MCM5 SMC5 INTS3 NDUFS1 NDUFS3 BAP1 PAX8 DDX23 TAOK1 TAF4 PLEC ASCC3 GCN1 GRWD1 UBR4 USP24 DNM1L RPSA IPO4 DIS3 TBL3 COL18A1 DDX20 PAX9 ARHGEF2 MAP2K2 AGRN SNRNP200 ATP5F1B XPOT | 7.06e-05 | 1403 | 272 | 37 | int:NR2C2 |
| Interaction | UBXN7 interactions | DDX59 KDM5C PSMC6 PSMD11 DPP8 BRWD3 MAP3K1 UBR4 BIRC2 DNM1L IPO4 CYFIP2 ATAD3B | 7.39e-05 | 267 | 272 | 13 | int:UBXN7 |
| Interaction | P2RY6 interactions | PSMC6 PSMD11 ERLEC1 ITPR3 GCN1 ST7 UBR4 IPO4 RFC3 NBAS GEMIN4 DDX20 PBXIP1 ATP5F1B XPOT HELLS | 7.46e-05 | 385 | 272 | 16 | int:P2RY6 |
| Interaction | RHOA interactions | NET1 LSG1 EIF4A3 DGKQ ITGA2 NDUFS1 NDUFS3 ADCY9 MFF MAP3K1 BAP1 ITPR3 FAT1 UBA1 FGB GCN1 PKN3 ARAP2 PTPMT1 GRWD1 DSC3 ST7 BIRC2 IPO4 HDAC7 CYFIP2 RNF123 EGFR NISCH GEMIN4 CTNNA1 ARHGEF2 MAP2K2 | 8.08e-05 | 1199 | 272 | 33 | int:RHOA |
| Interaction | LMBR1L interactions | SARM1 PSMC6 PSMD11 ERLEC1 NDUFS3 ITPR3 CHPF2 ASCC3 GCN1 PTPMT1 DYNC2H1 UBR4 USP24 OBSL1 BTAF1 IPO4 RFC3 TARS2 TBL3 COG8 ATAD3B NISCH GEMIN4 DDX20 CTNNA1 ARHGEF2 XPOT HELLS | 8.65e-05 | 946 | 272 | 28 | int:LMBR1L |
| Interaction | EEF1A2 interactions | CYLD PSG1 MCM5 SMC5 BAP1 FGB LRRC56 DDHD2 GRWD1 OBSL1 RPSA RNF123 OTUD4 AGRN | 1.08e-04 | 316 | 272 | 14 | int:EEF1A2 |
| Interaction | KRT8 interactions | CYLD LSG1 LRRC49 BAP1 ITPR3 PLEC DNMBP TROAP UBR4 OBSL1 KRT75 EGFR RNF38 OTUD4 ATP5F1B XPOT PCNT | 1.12e-04 | 441 | 272 | 17 | int:KRT8 |
| Interaction | HCST interactions | SARM1 NCEH1 PKN3 USP24 BTAF1 RFC3 LPCAT3 GEMIN4 DDX20 WDFY3 HELLS | 1.13e-04 | 205 | 272 | 11 | int:HCST |
| Interaction | CDH5 interactions | 1.16e-04 | 109 | 272 | 8 | int:CDH5 | |
| Interaction | FBXO6 interactions | RPL32 EIF4A3 GARS1 PSMC6 MCM5 NDUFS1 ERLEC1 CHPF2 TAF4 GCN1 HSPG2 PTPMT1 DSC3 RFC3 COL18A1 ATAD3B EGFR CSPG4 ARHGEF2 AGRN SNRNP200 ATP5F1B XPOT | 1.19e-04 | 717 | 272 | 23 | int:FBXO6 |
| Interaction | SPTBN2 interactions | MYO1C MYCBP2 KDM5C SPTA1 BAP1 OBSL1 CYFIP2 SSUH2 RNF123 PCNT | 1.20e-04 | 172 | 272 | 10 | int:SPTBN2 |
| Interaction | PI15 interactions | 1.31e-04 | 83 | 272 | 7 | int:PI15 | |
| Interaction | SORBS2 interactions | 1.32e-04 | 111 | 272 | 8 | int:SORBS2 | |
| Interaction | GPR17 interactions | INTS3 MAP3K4 USP24 BTAF1 COG8 NBAS RIF1 LPCAT3 GEMIN4 DDX20 WDFY3 SAYSD1 XPOT | 1.32e-04 | 283 | 272 | 13 | int:GPR17 |
| Interaction | MACF1 interactions | MYCBP2 BRWD3 BAP1 HECW2 DLG4 LRRC7 PLEC VCL OBSL1 CTNNA1 ATP5F1B PCNT | 1.42e-04 | 247 | 272 | 12 | int:MACF1 |
| Interaction | FBXO22 interactions | CYLD MYO7A KDM5C PSMC6 NEB SMC5 MAP3K4 NBEAL2 FGB ASCC2 DDX23 TAOK1 TAF4 ASCC3 PCDHB6 CTNNA1 HYDIN XPOT HELLS | 1.47e-04 | 540 | 272 | 19 | int:FBXO22 |
| Interaction | PRMT1 interactions | CYLD MYO1C EIF4A3 MCM5 PSMD11 LARP4 UBA1 DDX23 TAF4 PLEC GRWD1 UBR4 OBSL1 DNM1L RPSA SRBD1 DIS3 RIF1 EGFR GEMIN4 OTUD4 DDX20 WDFY3 ARHGEF2 SNRNP200 ZMYM5 ATP5F1B | 1.56e-04 | 929 | 272 | 27 | int:PRMT1 |
| Interaction | DLGAP1 interactions | 1.74e-04 | 180 | 272 | 10 | int:DLGAP1 | |
| Interaction | PSG3 interactions | 1.96e-04 | 22 | 272 | 4 | int:PSG3 | |
| Interaction | ACTC1 interactions | SART3 RPL32 MYO1C EIF4A3 KDM3B DAPK3 TWF2 BAP1 UBA1 DDX23 PLEC VCL OBSL1 DNM1L RPSA GRIN1 GSN CYFIP2 RIF1 PHACTR3 SNRNP200 ATP5F1B | 1.97e-04 | 694 | 272 | 22 | int:ACTC1 |
| Interaction | PSG8 interactions | 2.17e-04 | 41 | 272 | 5 | int:PSG8 | |
| Interaction | C9orf72 interactions | RPL32 MYO1C MYCBP2 EIF4A3 HLA-DQB1 GARS1 PSMC6 MCM5 PSMD11 NDUFS1 NDUFS3 UBA1 DDX23 ASCC3 GCN1 VCL PTPMT1 ST7 UBR4 RPSA BTAF1 IPO4 RFC3 TARS2 DIS3 TBL3 RIF1 ATAD3B GEMIN4 DDX20 SNRNP200 ATP5F1B XPOT HELLS | 2.18e-04 | 1319 | 272 | 34 | int:C9orf72 |
| Interaction | DNAJC7 interactions | ATG2A ADCY9 BAP1 ITPR3 DDHD2 ASCC3 DYNC2H1 OBSL1 DNM1L IPO4 TARS2 CYFIP2 EGFR BBS7 HERC4 PCNT | 2.31e-04 | 425 | 272 | 16 | int:DNAJC7 |
| Interaction | LLCFC1 interactions | 2.40e-04 | 121 | 272 | 8 | int:LLCFC1 | |
| Interaction | BRF2 interactions | 2.44e-04 | 42 | 272 | 5 | int:BRF2 | |
| Interaction | MYH9 interactions | CYLD MYO1C EIF4A3 KDM3B PSMC6 DAPK3 MCM5 TWF2 PSMD11 SMC5 BAP1 ITPR3 AGO3 ASCC2 PLEC DNAH6 VCL GRIN1 PARP14 ATP13A2 GSN RNF123 EGFR | 2.46e-04 | 754 | 272 | 23 | int:MYH9 |
| Interaction | UBE2A interactions | EIF4A3 SPTA1 UBA1 GCN1 PKN3 UBR4 BTAF1 RNF123 NISCH CTNNA1 ARHGEF2 | 2.64e-04 | 226 | 272 | 11 | int:UBE2A |
| Interaction | HSP90AA5P interactions | 2.66e-04 | 93 | 272 | 7 | int:HSP90AA5P | |
| Interaction | YWHAQ interactions | CYLD MYCBP2 EIF4A3 SPTA1 DAPK3 PSMD11 NEB SMC5 MFF MAP3K1 BAP1 KCNK3 FGB TAOK1 PLEC DNMBP GCN1 KLC3 VCL ARAP2 PARP8 PAK5 OBSL1 DNM1L HDAC7 EGFR PLEKHM3 ARHGEF2 MAP2K2 ATP5F1B | 2.68e-04 | 1118 | 272 | 30 | int:YWHAQ |
| Interaction | EED interactions | RPL32 MYO1C MYCBP2 EIF4A3 GARS1 UTP14A MCM5 TWF2 PSMD11 PSPH SMC5 INTS3 NDUFS1 UBA1 SUPT6H PLEC ASCC3 FTO GNL1 HSPG2 UBR4 DNM1L RPSA IPO4 TARS2 DIS3 TBL3 GSN RIF1 CTNNA1 AGRN SNRNP200 ATP5F1B XPOT PCNT HELLS | 2.72e-04 | 1445 | 272 | 36 | int:EED |
| Interaction | LIPT2 interactions | 2.72e-04 | 10 | 272 | 3 | int:LIPT2 | |
| Interaction | GUCA1A interactions | 2.72e-04 | 10 | 272 | 3 | int:GUCA1A | |
| Interaction | TULP3 interactions | HBS1L NEB ASCC2 FTO DNMBP GNL1 HSPG2 OBSL1 BIRC2 RFC3 TARS2 DIS3 ARHGEF2 SENP7 | 2.75e-04 | 346 | 272 | 14 | int:TULP3 |
| Interaction | CHRM4 interactions | 2.84e-04 | 94 | 272 | 7 | int:CHRM4 | |
| Interaction | ZBTB44 interactions | 2.86e-04 | 67 | 272 | 6 | int:ZBTB44 | |
| Interaction | KCTD13 interactions | SART3 DENND2A RPL32 MYO1C MYO7A SPTA1 LRRC49 DAPK3 TWF2 ITGA2 NDUFS1 NDUFS3 UBA1 HECW2 SLC27A1 DLG4 LRRC7 PLEC DNAH6 DAGLA VCL DNM1L RPSA GRIN1 ADAM22 GSN CYFIP2 AGO1 NISCH OTUD4 CTNNA1 ARHGEF2 SNRNP200 PBXIP1 ATP5F1B | 2.88e-04 | 1394 | 272 | 35 | int:KCTD13 |
| Cytoband | 19q13.2 | 7.17e-05 | 164 | 280 | 7 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.00e-04 | 298 | 280 | 9 | chr5q31 | |
| Cytoband | 3p25-p24 | 2.21e-04 | 4 | 280 | 2 | 3p25-p24 | |
| Cytoband | 15q15.3 | 4.67e-04 | 25 | 280 | 3 | 15q15.3 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.50e-10 | 11 | 200 | 6 | 1315 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 4.52e-05 | 7 | 200 | 3 | 570 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 9.09e-05 | 22 | 200 | 4 | 464 | |
| GeneFamily | DEAD-box helicases | 9.61e-05 | 42 | 200 | 5 | 499 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.07e-04 | 9 | 200 | 3 | 1230 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.30e-04 | 24 | 200 | 4 | 654 | |
| GeneFamily | PRAME family | 2.27e-03 | 24 | 200 | 3 | 686 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.47e-03 | 7 | 200 | 2 | 1113 | |
| GeneFamily | EMI domain containing | 2.47e-03 | 7 | 200 | 2 | 540 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 2.47e-03 | 7 | 200 | 2 | 1201 | |
| GeneFamily | SUMO specific peptidases | 2.47e-03 | 7 | 200 | 2 | 984 | |
| GeneFamily | AAA ATPases | 2.79e-03 | 53 | 200 | 4 | 413 | |
| GeneFamily | Argonaute/PIWI family | 3.26e-03 | 8 | 200 | 2 | 408 | |
| GeneFamily | Gelsolin/villins | 3.26e-03 | 8 | 200 | 2 | 950 | |
| GeneFamily | Paired boxes | 4.16e-03 | 9 | 200 | 2 | 675 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 1.36e-06 | 102 | 276 | 9 | M10290 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN | GARS1 PSMD11 IL1RL2 NBEAL2 RCE1 EFL1 TOR2A BTAF1 ATP13A2 RIF1 FBXO31 GEMIN4 | 1.55e-06 | 200 | 276 | 12 | M4300 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 3.89e-06 | 87 | 276 | 8 | MM851 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYCBP2 KDM3B MGLL SMC5 LARP4 ADCY9 MAP3K4 FAT1 TAF4 ASCC3 FTO DNMBP VCL ARAP2 DOP1B CHST3 USP24 BTAF1 NBAS RIF1 EGFR OTUD4 WDFY3 HERC4 PCNT | 4.76e-06 | 856 | 276 | 25 | M4500 |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP | UTP14A ERLEC1 ATAD3C NCEH1 ARAP2 RILPL2 SRBD1 SOCS1 WDFY3 THNSL2 HERC4 | 6.58e-06 | 192 | 276 | 11 | M7558 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | KDM5C SARM1 ATG2A ADCY9 ITPR3 AP1G2 PLEC DOP1B OBSL1 PPARD NISCH LRP4 AGRN | 8.20e-06 | 276 | 276 | 13 | M3063 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.99e-05 | 32 | 276 | 5 | MM2 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | MCM5 ADGRV1 FNDC1 FAT1 SULF1 ARAP2 TROAP RFC3 MMRN1 AGO1 CFAP44 PBXIP1 HYDIN | 2.53e-05 | 307 | 276 | 13 | M39058 |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 3.13e-05 | 35 | 276 | 5 | MM757 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | NET1 DAPK3 RRAD FNDC1 KCNK3 HSPG2 LEFTY2 FOXP4 ADAMTS6 PBXIP1 | 3.43e-05 | 189 | 276 | 10 | M45678 |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP | 5.31e-05 | 199 | 276 | 10 | M9759 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP | 5.31e-05 | 199 | 276 | 10 | M9782 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_UP | EXOC3L1 PLEC ST7 PCDHB2 PRAMEF8 RNF123 NPHP3 AGO1 NISCH SNRNP200 | 5.54e-05 | 200 | 276 | 10 | M6390 |
| Coexpression | GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | MYO1C CYTH3 LARP4 SLC22A17 PLEC RILPL2 DYNC2H1 ADAMTS6 FBXO31 PHACTR3 | 5.54e-05 | 200 | 276 | 10 | M9166 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | CYTH3 ITPR3 COL21A1 SULF1 PKN3 THSD7A RFC3 SSUH2 ADAMTS6 AOPEP ROBO2 SENP7 | 5.64e-05 | 286 | 276 | 12 | M45746 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 6.08e-05 | 40 | 276 | 5 | M5887 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | DENND2A ADGRB2 EMILIN3 GALNT16 ADCY8 COL21A1 MOCS1 COL6A3 ULBP2 SOCS1 PAX9 | 3.31e-08 | 189 | 279 | 11 | 473b01c9162b12b90a617c600238436177a0d18d |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDGFRB CYTH3 DDIT4L FNDC1 FAT1 COL6A3 THSD7A CD248 LAMA4 EGFR CSPG4 | 3.69e-08 | 191 | 279 | 11 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | DENND2A ADGRB2 EMILIN3 GALNT16 ADCY8 FNDC1 COL21A1 SULF1 GALNT8 COL6A3 PAX9 | 3.89e-08 | 192 | 279 | 11 | 4ed5040594ba2d0639f0990697504ecef872ca70 |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | DENND2A ADGRB2 EMILIN3 GALNT16 ADCY8 FNDC1 COL21A1 SULF1 GALNT8 COL6A3 PAX9 | 3.89e-08 | 192 | 279 | 11 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A PDGFRB FNDC1 FAT1 SULF1 KCNK3 MOCS1 COL6A3 LAMA4 COL18A1 CSPG4 | 4.32e-08 | 194 | 279 | 11 | 2d66091097e106c7bee22e5281f50724700bdf8d |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | DDIT4L FSTL4 EMILIN3 MGLL RRAD KCNK3 VCL COL6A3 GSN AOPEP PBXIP1 | 4.56e-08 | 195 | 279 | 11 | bff7685784688425bebd78b0f284a6d4475a9415 |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | PDGFRB MGLL RRAD FNDC1 FAT1 KCNK3 MOCS1 VCL LEFTY2 AOPEP CSPG4 | 5.33e-08 | 198 | 279 | 11 | c9c96066c7fa897b583657f0b77ea093920ae9ba |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB EMILIN3 GALNT16 FNDC1 COL21A1 SULF1 COL6A3 CD248 LAMA4 EGFR CSPG4 | 5.61e-08 | 199 | 279 | 11 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.93e-07 | 186 | 279 | 10 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PDGFRB RRAD GALNT16 ADCY9 KCNK3 VCL CD248 LAMA4 CSPG4 PRKAR1B | 3.24e-07 | 188 | 279 | 10 | a906c29e3fda22eecfec3e5cac706c417bf2b7a4 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | DENND2A MGLL MAP3K1 ITPR3 PAX8 MYO3B MYRFL HDAC7 PHACTR3 HYDIN | 3.57e-07 | 190 | 279 | 10 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PDGFRB RRAD GALNT16 ADCY9 KCNK3 VCL CD248 LAMA4 CSPG4 PRKAR1B | 3.57e-07 | 190 | 279 | 10 | 951e067d14412db67dc3babcdf61e41717d7b429 |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 279 | 10 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-07 | 192 | 279 | 10 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ITGA2 ADGRV1 ZNF608 COL21A1 DNAH6 DYNC2H1 WDPCP EGFR CFAP44 HYDIN | 4.12e-07 | 193 | 279 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | E12.5-Mesenchymal-myocytic_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.53e-07 | 195 | 279 | 10 | aed243418cdb5df4563a7b935c1ecbd744590901 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | GALNT16 FNDC1 COL21A1 SULF1 CA4 COL6A3 CD248 PAK5 KRT75 PAX9 | 4.75e-07 | 196 | 279 | 10 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | GALNT16 FNDC1 COL21A1 SULF1 CA4 COL6A3 CD248 PAK5 KRT75 PAX9 | 4.75e-07 | 196 | 279 | 10 | ee45e4de9d706ec87094e87f47d3e514539b8092 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | PDGFRB FAT1 SULF1 COL6A3 CD248 DYNC2H1 LAMA4 EGFR CSPG4 ROBO2 | 4.98e-07 | 197 | 279 | 10 | c165c6fd12dc649b39e920d8528e2eb65c61956b |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | DENND2A PDGFRB MGLL RRAD KCNK3 MOCS1 COL6A3 CD248 COL18A1 CSPG4 | 4.98e-07 | 197 | 279 | 10 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | PDGFRB FNDC1 HSPG2 COL6A3 CD248 DYNC2H1 OBSL1 LAMA4 COL18A1 EGFR | 5.21e-07 | 198 | 279 | 10 | e8c0fbf306fae13e97caa294d7c99a564bd97130 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.21e-07 | 198 | 279 | 10 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | DENND2A PDGFRB FSTL5 FNDC1 FAT1 COL6A3 LAMA4 ADAM22 LRP4 ROBO2 | 5.71e-07 | 200 | 279 | 10 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | DENND2A PDGFRB FNDC1 FAT1 VCL COL6A3 CD248 LAMA4 CSPG4 ROBO2 | 5.71e-07 | 200 | 279 | 10 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.52e-06 | 173 | 279 | 9 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-06 | 173 | 279 | 9 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-06 | 179 | 279 | 9 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 179 | 279 | 9 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DENND2A PDGFRB RRAD GALNT16 ADCY8 KCNK3 CSPG4 PRKAR1B FRMPD3 | 2.02e-06 | 179 | 279 | 9 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DENND2A PDGFRB RRAD GALNT16 ADCY8 KCNK3 CSPG4 PRKAR1B FRMPD3 | 2.02e-06 | 179 | 279 | 9 | bfc226bcf0b93525992344f968268a261d86fcbf |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 183 | 279 | 9 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 183 | 279 | 9 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 183 | 279 | 9 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 183 | 279 | 9 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-06 | 184 | 279 | 9 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-06 | 184 | 279 | 9 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-06 | 184 | 279 | 9 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-06 | 184 | 279 | 9 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 187 | 279 | 9 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 187 | 279 | 9 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 187 | 279 | 9 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 2.89e-06 | 187 | 279 | 9 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.89e-06 | 187 | 279 | 9 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-06 | 188 | 279 | 9 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 189 | 279 | 9 | 62e46d59d3b89d4566b595c704d8b02f1ea9060b | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 189 | 279 | 9 | 37ce47abd6f96df04d35a4a6189d007bef5ccc94 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 189 | 279 | 9 | b55324cb365a827d071952709bbf0e8ef8c313de | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 3.15e-06 | 189 | 279 | 9 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 190 | 279 | 9 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 190 | 279 | 9 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 190 | 279 | 9 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.29e-06 | 190 | 279 | 9 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.29e-06 | 190 | 279 | 9 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.29e-06 | 190 | 279 | 9 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 192 | 279 | 9 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 192 | 279 | 9 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-06 | 192 | 279 | 9 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 193 | 279 | 9 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.74e-06 | 193 | 279 | 9 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | DENND2A PDGFRB ITGA2 COL21A1 MOCS1 COL6A3 LAMA4 PHACTR3 ROBO2 | 3.74e-06 | 193 | 279 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-06 | 194 | 279 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-06 | 194 | 279 | 9 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 195 | 279 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.07e-06 | 195 | 279 | 9 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-06 | 195 | 279 | 9 | 9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 195 | 279 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 4.24e-06 | 196 | 279 | 9 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-06 | 196 | 279 | 9 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.24e-06 | 196 | 279 | 9 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.24e-06 | 196 | 279 | 9 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-06 | 196 | 279 | 9 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.42e-06 | 197 | 279 | 9 | e132f4b9deef6a565262c0aa0863cafe28f248e6 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.42e-06 | 197 | 279 | 9 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.42e-06 | 197 | 279 | 9 | 8c728cd3c0382c4f3e4b78647b6e1447bb40ace1 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.60e-06 | 198 | 279 | 9 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-06 | 198 | 279 | 9 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 198 | 279 | 9 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.60e-06 | 198 | 279 | 9 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-06 | 198 | 279 | 9 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.80e-06 | 199 | 279 | 9 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | medial-mesenchymal-Pericyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 200 | 279 | 9 | bbda454260016be92b539e220ecf7bcbbc6139e4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 200 | 279 | 9 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.00e-06 | 200 | 279 | 9 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | medial-mesenchymal-Pericyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 200 | 279 | 9 | f36d7cb6345daccebf76997f998e35d959b59452 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.00e-06 | 200 | 279 | 9 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-06 | 200 | 279 | 9 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 200 | 279 | 9 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.00e-06 | 200 | 279 | 9 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 200 | 279 | 9 | f9bc22ff17bb1c751e6b05bca3f403836f33459a | |
| ToppCell | distal-1-mesenchymal-Pericyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DENND2A PDGFRB RRAD COL21A1 KCNK3 MOCS1 COL6A3 CD248 COL18A1 | 5.00e-06 | 200 | 279 | 9 | ff205afda57b9267016f0c937445da1b0266af9b |
| ToppCell | Parenchymal-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.00e-06 | 200 | 279 | 9 | 0a7640db28c708003d5da2d19eb651f6fedfd710 | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 200 | 279 | 9 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.00e-06 | 200 | 279 | 9 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | medial-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 200 | 279 | 9 | 9820fb4f6efcdfc6de937ef2302a98b48426baa3 | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.00e-06 | 200 | 279 | 9 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-06 | 200 | 279 | 9 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(1)_24hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 5.50e-06 | 71 | 279 | 6 | 6aa56b0daaeb5e0ae30619f9c6945c8e42899b27 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.19e-06 | 155 | 279 | 8 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.49e-06 | 156 | 279 | 8 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 167 | 279 | 8 | 961e722442d786ab15d1e490941d2be265a9057a | |
| Computational | Neighborhood of EGFR | 5.84e-06 | 32 | 157 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of CDKN1C | 3.88e-05 | 27 | 157 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of TIMP2 | 5.10e-05 | 46 | 157 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 7.34e-05 | 49 | 157 | 6 | GNF2_KISS1 | |
| Computational | Neighborhood of IGFBP1 | 1.42e-04 | 35 | 157 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 3.43e-04 | 42 | 157 | 5 | GNF2_MMP11 | |
| Disease | cD177 antigen measurement | 4.38e-07 | 18 | 265 | 5 | EFO_0021866 | |
| Disease | Disproportionate short stature | 6.13e-06 | 77 | 265 | 7 | C0878659 | |
| Disease | Ciliopathies | 7.08e-06 | 110 | 265 | 8 | C4277690 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.09e-05 | 33 | 265 | 5 | DOID:10003 (is_implicated_in) | |
| Disease | Osteoporosis, Age-Related | 1.82e-05 | 61 | 265 | 6 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 1.82e-05 | 61 | 265 | 6 | C0751406 | |
| Disease | Osteoporosis, Senile | 1.82e-05 | 61 | 265 | 6 | C0029459 | |
| Disease | Osteoporosis | 2.19e-05 | 63 | 265 | 6 | C0029456 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 8.04e-05 | 2 | 265 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | level of UL16-binding protein 6 in blood serum | 8.04e-05 | 2 | 265 | 2 | OBA_2043185 | |
| Disease | Malignant neoplasm of breast | DDX59 NET1 RRAD GALNT16 NDUFS3 MAP3K1 BAP1 EXOC3L1 LRRC7 FTO VDR RCE1 DSC3 DYNC2H1 UBR4 BIRC2 HDAC7 GSN RIF1 FOXP4 LIPE EGFR NISCH | 1.17e-04 | 1074 | 265 | 23 | C0006142 |
| Disease | Disorder of eye | 1.37e-04 | 212 | 265 | 9 | C0015397 | |
| Disease | Head and Neck Neoplasms | 2.12e-04 | 33 | 265 | 4 | C0018671 | |
| Disease | Intellectual Disability | PDGFRB EIF4A3 KDM5C KDM3B BRWD3 DLG4 TAOK1 TAF2 ASCC3 GRIN1 COL18A1 AGO1 BBS7 | 2.25e-04 | 447 | 265 | 13 | C3714756 |
| Disease | height-adjusted body mass index | 2.40e-04 | 3 | 265 | 2 | EFO_0005851 | |
| Disease | pyridoxamine measurement | 2.40e-04 | 3 | 265 | 2 | EFO_0021837 | |
| Disease | Behcet's disease (is_implicated_in) | 2.99e-04 | 36 | 265 | 4 | DOID:13241 (is_implicated_in) | |
| Disease | Graves' disease (is_implicated_in) | 4.08e-04 | 39 | 265 | 4 | DOID:12361 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.66e-04 | 152 | 265 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | neuromuscular disease (implicated_via_orthology) | 4.76e-04 | 4 | 265 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | secondary hyperparathyroidism (biomarker_via_orthology) | 4.76e-04 | 4 | 265 | 2 | DOID:12466 (biomarker_via_orthology) | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 4.76e-04 | 4 | 265 | 2 | EFO_0801909 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.79e-04 | 206 | 265 | 8 | C0152013 | |
| Disease | Malignant Head and Neck Neoplasm | 6.51e-04 | 44 | 265 | 4 | C0278996 | |
| Disease | polymyositis | 7.29e-04 | 20 | 265 | 3 | EFO_0003063 | |
| Disease | intraocular pressure measurement | ADGRB2 MFF COL6A3 PNPLA2 THSD7A DYNC2H1 ST7 ATP13A2 ANKH NPHP3 ADAMTS6 CSPG4 LRP4 | 7.62e-04 | 509 | 265 | 13 | EFO_0004695 |
| Disease | FEV/FEC ratio | HLA-DQB1 UTP14A DDIT4L NEB ADCY8 MAP3K1 SPTBN5 COL21A1 SULF1 ASCC2 FTO ARAP2 HSPG2 COL6A3 MYRFL RFC3 ATP13A2 CYFIP2 LIMK1 CSPG4 RNF38 OTUD4 MYO15A | 7.68e-04 | 1228 | 265 | 23 | EFO_0004713 |
| Disease | small cell lung carcinoma | 7.81e-04 | 80 | 265 | 5 | EFO_0000702 | |
| Disease | Thymoma | 7.89e-04 | 5 | 265 | 2 | C0040100 | |
| Disease | atopy | 7.89e-04 | 5 | 265 | 2 | EFO_0002686 | |
| Disease | Nonsyndromic Deafness | 8.27e-04 | 81 | 265 | 5 | C3711374 | |
| Disease | Morbilliform Drug Reaction | 1.11e-03 | 23 | 265 | 3 | C0406537 | |
| Disease | Drug Eruptions | 1.11e-03 | 23 | 265 | 3 | C0011609 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 1.18e-03 | 6 | 265 | 2 | EFO_0801907 | |
| Disease | nischarin measurement | 1.18e-03 | 6 | 265 | 2 | EFO_0801841 | |
| Disease | Myasthenic Syndromes, Congenital | 1.26e-03 | 24 | 265 | 3 | C0751882 | |
| Disease | Cancer of Head | 1.26e-03 | 24 | 265 | 3 | C0751177 | |
| Disease | Head Neoplasms | 1.26e-03 | 24 | 265 | 3 | C0018675 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.26e-03 | 24 | 265 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.26e-03 | 24 | 265 | 3 | C3805278 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 1.26e-03 | 24 | 265 | 3 | C0887900 | |
| Disease | Neck Neoplasms | 1.42e-03 | 25 | 265 | 3 | C0027533 | |
| Disease | Cancer of Neck | 1.42e-03 | 25 | 265 | 3 | C0746787 | |
| Disease | breast cancer (is_marker_for) | 1.47e-03 | 185 | 265 | 7 | DOID:1612 (is_marker_for) | |
| Disease | comparative body size at age 10, self-reported | ZBTB48 HLA-DQB1 ADCY8 NDUFS3 ADCY9 COL21A1 FTO GCN1 PRKAR1B ROBO2 ARHGEF2 | 1.57e-03 | 420 | 265 | 11 | EFO_0009819 |
| Disease | Cholangiocarcinoma | 1.60e-03 | 26 | 265 | 3 | C0206698 | |
| Disease | Thymic Carcinoma | 1.64e-03 | 7 | 265 | 2 | C0205969 | |
| Disease | pemphigus (is_implicated_in) | 1.64e-03 | 7 | 265 | 2 | DOID:9182 (is_implicated_in) | |
| Disease | heterogeneous nuclear ribonucleoproteins C1/C2 measurement | 1.64e-03 | 7 | 265 | 2 | EFO_0801675 | |
| Disease | basal cell carcinoma | 1.66e-03 | 189 | 265 | 7 | EFO_0004193 | |
| Disease | bipolar I disorder | 1.77e-03 | 141 | 265 | 6 | EFO_0009963 | |
| Disease | rheumatoid arthritis (is_implicated_in) | 1.84e-03 | 58 | 265 | 4 | DOID:7148 (is_implicated_in) | |
| Disease | melanoma | 1.90e-03 | 248 | 265 | 8 | C0025202 | |
| Disease | Alzheimer disease, APOE carrier status | 1.94e-03 | 98 | 265 | 5 | EFO_0007659, MONDO_0004975 | |
| Disease | hypertension | 1.94e-03 | 307 | 265 | 9 | EFO_0000537 | |
| Disease | tuberculosis (is_implicated_in) | 1.99e-03 | 28 | 265 | 3 | DOID:399 (is_implicated_in) | |
| Disease | corpus callosum volume measurement | 2.12e-03 | 100 | 265 | 5 | EFO_0010299 | |
| Disease | non-high density lipoprotein cholesterol measurement | HBS1L PSG1 PSG3 HLA-DQB1 SPTA1 SARM1 WDR81 DGKQ KCNK3 FGB ASCC3 PKN3 WDPCP THNSL2 HYDIN | 2.14e-03 | 713 | 265 | 15 | EFO_0005689 |
| Disease | Williams Syndrome | 2.17e-03 | 8 | 265 | 2 | C0175702 | |
| Disease | chitinase-3-like protein 2 measurement | 2.17e-03 | 8 | 265 | 2 | EFO_0801471 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 2.17e-03 | 8 | 265 | 2 | C0796250 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 2.17e-03 | 8 | 265 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | Congenital Hydrocephalus | 2.17e-03 | 8 | 265 | 2 | C0020256 | |
| Disease | calpastatin measurement | 2.17e-03 | 8 | 265 | 2 | EFO_0008065 | |
| Disease | vitiligo (is_marker_for) | 2.17e-03 | 8 | 265 | 2 | DOID:12306 (is_marker_for) | |
| Disease | hemorrhoid | 2.18e-03 | 147 | 265 | 6 | EFO_0009552 | |
| Disease | rhinitis (is_implicated_in) | 2.43e-03 | 30 | 265 | 3 | DOID:4483 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder | 2.67e-03 | 31 | 265 | 3 | EFO_0003888, MONDO_0004985 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 2.77e-03 | 9 | 265 | 2 | C0085548 | |
| Disease | alopecia areata (is_implicated_in) | 2.77e-03 | 9 | 265 | 2 | DOID:986 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | HBS1L PSG1 SARM1 WDR81 KCNK3 FGB DLG4 TAOK1 PLEC PKN3 USP24 NPHP3 NISCH HYDIN | 2.88e-03 | 663 | 265 | 14 | EFO_0004615 |
| Disease | Mammary Carcinoma, Human | RRAD GALNT16 NDUFS3 MAP3K1 BAP1 FTO VDR DSC3 DYNC2H1 BIRC2 EGFR NISCH | 3.01e-03 | 525 | 265 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | RRAD GALNT16 NDUFS3 MAP3K1 BAP1 FTO VDR DSC3 DYNC2H1 BIRC2 EGFR NISCH | 3.01e-03 | 525 | 265 | 12 | C1257931 |
| Disease | Mammary Neoplasms | RRAD GALNT16 NDUFS3 MAP3K1 BAP1 FTO VDR DSC3 DYNC2H1 BIRC2 EGFR NISCH | 3.10e-03 | 527 | 265 | 12 | C1458155 |
| Disease | Short Stature, CTCAE | 3.45e-03 | 10 | 265 | 2 | C2919142 | |
| Disease | Odontome | 3.45e-03 | 10 | 265 | 2 | C0524730 | |
| Disease | Optic Atrophy | 3.45e-03 | 10 | 265 | 2 | C0029124 | |
| Disease | Tooth Abnormalities | 3.45e-03 | 10 | 265 | 2 | C0040427 | |
| Disease | Short stature | 3.45e-03 | 10 | 265 | 2 | C0349588 | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 3.45e-03 | 10 | 265 | 2 | EFO_0020778 | |
| Disease | cervical carcinoma, Cervical Intraepithelial Neoplasia Grade 2/3 | 3.45e-03 | 10 | 265 | 2 | EFO_0001061, EFO_1000166 | |
| Disease | Head and Neck Carcinoma | 3.45e-03 | 10 | 265 | 2 | C3887461 | |
| Disease | beta thalassemia (is_implicated_in) | 3.45e-03 | 10 | 265 | 2 | DOID:12241 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, asthma | 3.45e-03 | 10 | 265 | 2 | EFO_0003888, MONDO_0004979 | |
| Disease | psoriasis (is_implicated_in) | 3.49e-03 | 34 | 265 | 3 | DOID:8893 (is_implicated_in) | |
| Disease | Breast Carcinoma | RRAD GALNT16 NDUFS3 MAP3K1 BAP1 FTO VDR DSC3 DYNC2H1 BIRC2 EGFR NISCH | 3.66e-03 | 538 | 265 | 12 | C0678222 |
| Disease | Kartagener Syndrome | 3.79e-03 | 35 | 265 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 3.79e-03 | 35 | 265 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 3.79e-03 | 35 | 265 | 3 | C4317124 | |
| Disease | Polydactyly | 4.17e-03 | 117 | 265 | 5 | C0152427 | |
| Disease | ovarian mucinous adenocarcinoma | 4.19e-03 | 11 | 265 | 2 | EFO_0006462 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 4.19e-03 | 11 | 265 | 2 | EFO_0021862 | |
| Disease | uveitis (implicated_via_orthology) | 4.19e-03 | 11 | 265 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | Developmental delay (disorder) | 4.44e-03 | 37 | 265 | 3 | C0424605 | |
| Disease | stenosing tenosynovitis | 5.00e-03 | 12 | 265 | 2 | EFO_0010822 | |
| Disease | C-C motif chemokine 28 measurement | 5.00e-03 | 12 | 265 | 2 | EFO_0020199 | |
| Disease | basal cell carcinoma (is_implicated_in) | 5.00e-03 | 12 | 265 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | response to angiotensin-converting enzyme inhibitor | 5.39e-03 | 78 | 265 | 4 | EFO_0005325 | |
| Disease | mean corpuscular hemoglobin concentration | HBS1L PSG1 EIF4A3 SPTA1 GARS1 DPP8 NEB ADCY9 HECW2 ASCC2 VIL1 HDAC7 RIF1 NPHP3 EGFR BBS7 OTUD4 MYO15A SENP7 | 5.47e-03 | 1105 | 265 | 19 | EFO_0004528 |
| Disease | cervical cancer | 5.54e-03 | 40 | 265 | 3 | MONDO_0002974 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPKLSEEQQRIIAIL | 121 | P11473 | |
| LIVTDNLVISIQREP | 716 | O60241 | |
| ENQRQERLVLSVLPR | 366 | P40145 | |
| QILRLANERFAVPEI | 266 | Q9GZN1 | |
| SQALQTLEPLRERVA | 111 | Q86VI1 | |
| RVRNPTVQLLLAEAE | 576 | Q86VI1 | |
| PLTLRQLEQQEEILR | 271 | Q96DZ1 | |
| PAQSLLELVEQVTRV | 146 | Q96Q91 | |
| ITPVLACQDRVLRVL | 161 | Q8IWZ6 | |
| QQLLLFLRVREAPTV | 331 | P59826 | |
| AVEPLARIIRVILQS | 196 | Q7RTX7 | |
| RLVLGQEELRLQTPA | 86 | Q6UVK1 | |
| IRELILRFISNPNSI | 166 | O00429 | |
| RPLALAFVELTVVQR | 556 | O15254 | |
| PILLVSEDQRSVQRA | 351 | O00481 | |
| TEREQTLQVLRRLFP | 251 | Q9Y672 | |
| LRSPQEEALQRLVNL | 731 | Q92974 | |
| DALVLRTQATQLPII | 571 | Q9HCU0 | |
| VINNILEERLAPTLS | 501 | Q9H1I8 | |
| LENIRPVLVINKIDR | 136 | Q7Z2Z2 | |
| LPFQRLVREIAQAIS | 66 | P0DPK5 | |
| TVRVQRPRQEIIEDL | 626 | Q9UL18 | |
| APDVARALLRQIQVS | 1216 | O00468 | |
| IRLIIERIGEPANVT | 51 | Q8WXG9 | |
| ENRFVERQSIVPLRL | 41 | Q9P0K1 | |
| VSDPFLQVQILRLLR | 241 | O75843 | |
| QIRLQVERQEVELPS | 796 | P52824 | |
| LEALQQLIRVTQPEL | 256 | Q92560 | |
| VLVQELEEHQLIPRR | 31 | Q6RI45 | |
| PEKLTQRIAQDVLRL | 81 | Q96D03 | |
| KERTERLVISPLNQL | 1096 | Q6XZF7 | |
| PSRVIEELNVVLQRS | 1676 | Q8WZ64 | |
| EELNVVLQRSRTLPK | 1681 | Q8WZ64 | |
| EEFRNQIVRELVTLP | 181 | Q8N6M6 | |
| TQILILAPTREIAVQ | 131 | Q9UHI6 | |
| RVQRPRQEIIQDLAS | 631 | Q9H9G7 | |
| REKQQRLNELLVVIP | 1606 | Q96MT7 | |
| LEERPLSRQVFIVQE | 1511 | Q2TAZ0 | |
| NIIVARLIVLTEDQP | 296 | Q9UKP5 | |
| PILNALEVQGRETRL | 81 | P06576 | |
| VLNRTPANLIQEIIL | 146 | Q8N428 | |
| EIKPAIRNQIIRELQ | 106 | P36507 | |
| LPEVVRQRIVDLAHQ | 26 | Q06710 | |
| QILNRERETVPVELE | 966 | Q01804 | |
| PVQRAELLQVLQSLE | 676 | P98160 | |
| PLVVRALELLEQAAV | 56 | Q96NA2 | |
| RELQETNLRAVSAPI | 436 | A6NNM3 | |
| RELQETNLRAVSAPI | 436 | A6NJZ7 | |
| VRLLQNVARIPEFEL | 256 | Q68E01 | |
| ENAERILISLRPQEL | 2011 | Q14573 | |
| ALVELQTQRPIALEL | 641 | Q9Y450 | |
| EVDPQLPRVVQTLLR | 371 | Q86XR2 | |
| IILPQLVLNRALDRE | 191 | Q9Y5E7 | |
| QLRRARQTDDVPIIL | 186 | P55042 | |
| FQDILVLTRPVTRNE | 406 | Q7Z628 | |
| VDGRLTVLRTIQLQP | 671 | Q9NRD9 | |
| LTIPVQRLLERQAIG | 281 | Q9P2P5 | |
| TVRRLVLPAVQLEDS | 951 | O75147 | |
| RILENIIQTVRTNFP | 611 | Q6IE37 | |
| LVREPSQRATAQELL | 681 | Q9P286 | |
| NSVVLTDRNVPLVIR | 1781 | Q14517 | |
| SRLPEQVELRRVQSL | 391 | Q96AD5 | |
| LVQTIEFAEQRIPVL | 491 | Q8N3A8 | |
| LPNAIRLRIVELAQL | 21 | P55771 | |
| LISQIQPEVDRERAV | 531 | Q9NRZ9 | |
| IQDSQLRVLLPALSR | 361 | Q5VTA0 | |
| IVVQIVDARNPLLFR | 176 | Q9H089 | |
| RRLLQVVEEPQALAA | 181 | Q9BQ67 | |
| QILDVLDENRRPVLR | 241 | Q9GZY8 | |
| IQLLNAVSRVERALP | 211 | Q99685 | |
| IPITVRQLEAIVRIA | 606 | P33992 | |
| IRQDRIVGVPLELEQ | 811 | Q96NW7 | |
| AREIQAVAELLQISP | 1506 | Q9UKN7 | |
| SEPELIERQRLELRQ | 31 | O14649 | |
| VQENRPTLTDIVELR | 446 | Q13201 | |
| LPVEQRNEILTAILA | 426 | Q9C0B1 | |
| ARNAILEELPRTVNT | 1616 | Q9Y3R5 | |
| ALPEVQLLQIRENVL | 156 | A1A4Y4 | |
| DIQVRETQALILAPT | 101 | P38919 | |
| ILTPTRELAIQIERQ | 276 | Q5T1V6 | |
| LPFQRLVREIAQAIS | 66 | P0DPK2 | |
| QQTVEIDLRHRIQLP | 341 | Q5XUX0 | |
| IPTNLRVLRSILENL | 191 | P02675 | |
| RNQVIAPLTEELVFR | 166 | Q9Y256 | |
| IPETREQALRIQTLG | 141 | Q96MA6 | |
| LQQELDSRPQLRSVL | 91 | Q96AB3 | |
| RIVQELPQLLDARSA | 311 | Q6PIU2 | |
| IVRRADRAAVPIVNL | 1631 | P39060 | |
| PQEDVERVQRLSLLL | 111 | Q4VXF1 | |
| VIESVNPCLILVVRR | 701 | Q5GLZ8 | |
| QVRSEVPAIDLARVL | 481 | P55259 | |
| LNRHTEILEILEIPQ | 146 | Q96MW5 | |
| IEREVNILREIRHPN | 61 | O43293 | |
| VDVDLQRITLPSINR | 281 | O94830 | |
| GLVLVPSRELAQQVR | 206 | Q9NUL7 | |
| IRLQLSRQPSADVLV | 246 | Q9NUL7 | |
| AQEVQEILPRAVREV | 501 | Q96LU7 | |
| REDPVLLQGIRVSIA | 101 | Q7LBC6 | |
| ALAQLRRIDQLTIDP | 486 | Q8IUZ0 | |
| VIVERQAARLIQESP | 391 | Q6P1A2 | |
| IRQAILETPDRQLTL | 476 | Q8IVH2 | |
| REQVLQPVSAELLEL | 101 | P36915 | |
| ERLSPEELVRQTRQV | 16 | Q6P597 | |
| ALRQIGSVIRNPEIL | 1561 | Q92616 | |
| QVIFPQDVLRLRAET | 426 | Q6ZWE6 | |
| LIERLGTPQQIAIAR | 1086 | Q96F07 | |
| AIILAPTRELAQQIE | 471 | Q9BUQ8 | |
| NSVPIQQEILVLRRE | 111 | Q16552 | |
| ISDLVLDVRQIPAAQ | 796 | P17301 | |
| PEERRGQVLILLVEQ | 1276 | A2RRP1 | |
| GPEIQLEVTQRALLR | 1636 | O95613 | |
| LLLNILDARVQAPRV | 336 | Q9NQS5 | |
| IRPDVVDIVAQLQRL | 131 | Q9NZB8 | |
| PQEDVERVQRLSLLL | 111 | A6NL05 | |
| VAQPTLDRVLIVDVQ | 516 | Q8N475 | |
| REQIIFIPESRLLNS | 136 | Q9Y5I3 | |
| SPRLLEQERVIELAV | 116 | Q96HP4 | |
| PLRSLTRQLVQDENV | 51 | Q8WUK0 | |
| PRLLEVTNTIRVENL | 221 | Q460N5 | |
| PSIEQRLQEVRESIR | 366 | Q86WN1 | |
| VDALVLNILPEVLER | 401 | Q9HB29 | |
| INIQLLAEDRLPRET | 411 | O95876 | |
| LFQQILVVQALRPDR | 3671 | Q8NCM8 | |
| QLELRTTLQRRVEPT | 116 | P01920 | |
| IALNTVERIPLENLQ | 91 | P00533 | |
| VERIPLENLQIIRGN | 96 | P00533 | |
| RVPLNEIVIRALDLV | 451 | Q9NQ11 | |
| ANIRDPLQIIKIIRE | 181 | Q9C0G6 | |
| RPRDLISNINVIVLE | 101 | P60568 | |
| QESRVVLLRNVTLLP | 2951 | Q4G0P3 | |
| TVFREPIQLHREQIL | 236 | P22748 | |
| RTLAVERLLEPLVTQ | 21 | P35221 | |
| DIPRVTALNRALVTV | 446 | Q14574 | |
| VTLAVQPRLLDILSE | 746 | O14981 | |
| LPLEEVLVVDLVNSR | 831 | Q9ULE3 | |
| RATVLIKRINVVPDQ | 326 | Q9BPX7 | |
| QLPAEILRQVTVHRD | 46 | Q5JV73 | |
| ANRRVLIENLIPDTV | 316 | Q4ZHG4 | |
| ILARIQEDRTVIVSP | 291 | Q9NY28 | |
| DRSQTRLQIVLISPE | 396 | Q6V1X1 | |
| VAQPALSRVLVVDIQ | 516 | Q6MZW2 | |
| TQLTREELSRLQPVL | 1206 | P12111 | |
| DLRQLQVRERPVALE | 81 | Q8IZI9 | |
| VCTDVIRAQLPVLLQ | 796 | Q96P44 | |
| RGIIPLENLSIREVE | 306 | O43739 | |
| LILATQRISRPIVNL | 246 | Q9HCJ1 | |
| LRRPASLIGQEVVLV | 971 | O60503 | |
| RLLSRPQDVLEGVVL | 131 | Q5T2N8 | |
| IAIFIRPRSLENVLE | 646 | P78352 | |
| LLRQLQLSEVPVLDR | 31 | O00292 | |
| ELLTIIQAIRAINPC | 111 | P43080 | |
| SSVLVQPLRELRSNV | 631 | Q71RC2 | |
| RQDPVELLLLSTQER | 751 | Q9Y4D2 | |
| TLPELQEQVRALRAE | 206 | Q6NY19 | |
| LLERLRELGVQPVVT | 176 | Q9UEF7 | |
| EIALLLNRPRAATVV | 326 | P31321 | |
| TGAQELLRVLRAQPV | 616 | P06396 | |
| LLRVLRAQPVQVAEG | 621 | P06396 | |
| VERNIRIIVPLNNRE | 56 | P01591 | |
| PLVQTELAVLEQRLV | 501 | Q9NT22 | |
| IGTPVIQLLNRVRQE | 266 | Q5T1A1 | |
| IQIDIQETILDLRTP | 156 | Q9NQM4 | |
| PNLNAIRSLEAVIRV | 876 | Q8WUI4 | |
| TQELLRTEIVNPLRI | 636 | Q9NQC7 | |
| DVLLTQEVRPRQSKL | 86 | Q5VWM4 | |
| QEVRPRQSKLQVLDL | 91 | Q5VWM4 | |
| ENRILILPNVTRNET | 291 | Q00888 | |
| PARIQLIFERALVEN | 326 | Q15020 | |
| IRRATEQLQIVLRAP | 21 | Q8TEX9 | |
| PRFTLQELRDVLQER | 131 | Q969X0 | |
| ENRILILPSVTRNET | 291 | P11464 | |
| RLRNLGQPVTLRVVE | 1006 | Q05469 | |
| LQINVPVRVLELSES | 411 | P09619 | |
| QTFVIPLERARELEI | 356 | Q6P5Z2 | |
| ENRILILPSVTRNET | 291 | Q16557 | |
| AIVSQQTPQRLLEVR | 261 | P40938 | |
| ARDAVRNLTEVVPQL | 781 | Q16363 | |
| RNLTEVVPQLLDQLR | 786 | Q16363 | |
| REEQPQLRLTLIALD | 201 | Q9Y5E3 | |
| AERIKLQRLLQPVVD | 671 | Q13233 | |
| TARQAIPDIINEILT | 286 | Q9Y6R4 | |
| RRAVQAAVTILIPEL | 1121 | Q6ZN16 | |
| SQRPAVEELERRNIL | 446 | Q96KR7 | |
| QLELVTRNRPLVVEK | 166 | P0C091 | |
| QIQAAFREPRLLVVT | 111 | P08865 | |
| LPEAVQRLVELQNTR | 696 | Q9BW92 | |
| TFLLQAPLQRRILEI | 871 | O00268 | |
| LLPDEQIVGISRIQR | 196 | Q8IV01 | |
| LVDRVFNRPRIETLQ | 161 | Q9Y3A2 | |
| LIVVPFREAALRVVQ | 356 | Q68CQ4 | |
| LNLSERIPRVILTNV | 156 | Q9BQF6 | |
| LTTPRREIVVQDVLN | 196 | Q8IYL2 | |
| IVERAAQLAIRVTNP | 111 | P62910 | |
| SRSPLQRIENEVELL | 301 | Q9H0F5 | |
| LTLANDRVPNVRVLL | 871 | Q8TF05 | |
| NVPRVEAIQDTILRA | 366 | Q03181 | |
| VLEAAQELLRNRPIS | 131 | Q9BVQ7 | |
| IQVRSRPVIIQELEN | 1441 | Q9UPZ6 | |
| LTVIQRDVQAILPLA | 431 | Q6IEE7 | |
| EAQSVLRILAERNRP | 251 | Q8WUG5 | |
| TVEPQRRLLLDIDIN | 836 | A0AVI2 | |
| RAEVRKLIPQLQVLD | 216 | Q8IYG6 | |
| QVRNRLEEVSPNLVR | 641 | P28331 | |
| QAIVPLQRSLEIRET | 961 | Q7Z494 | |
| EALNVIVRLIEQAPI | 161 | Q5UIP0 | |
| VRTLDNLNPDVRLIL | 816 | Q6P1X5 | |
| NLNPDVRLILEEITR | 821 | Q6P1X5 | |
| IISQPCLVEDVQRLR | 251 | A6NCM1 | |
| ENRILILPSVTRNET | 291 | Q9UQ74 | |
| ENRILILPSVTRNET | 291 | Q00887 | |
| LVDLTAVDVPTRQNR | 111 | O75489 | |
| FQELVLEPAQRRARL | 1766 | Q6ZNJ1 | |
| LEQNLIRVIEPFSRV | 331 | O00231 | |
| EEVLAPLRLAVRQQG | 61 | P41250 | |
| VIITILDQEPDVRNR | 506 | Q16819 | |
| GLPIRLVVAVNRNDI | 276 | Q86YJ6 | |
| VLRERPETVLIDLIQ | 281 | Q7L7X3 | |
| SEDVLRLLIPVRTVQ | 2061 | O75592 | |
| ENRILILPSVTRNET | 291 | Q13046 | |
| EINEIRSRVEVPLIA | 211 | Q9NRC1 | |
| VRIERSPLLDQVQTF | 61 | Q8N5I9 | |
| EDPAIRNVIVLQTVL | 81 | Q9Y2L1 | |
| VRPLQELCRQRIVAT | 171 | O15524 | |
| VELVQRAPEQLLALT | 1281 | Q7RTU9 | |
| VSIARRVQDPLAELV | 656 | Q8N5C6 | |
| ERVEVQVLNIDIPRS | 971 | Q8N5C6 | |
| QVLNIDIPRSRITLD | 976 | Q8N5C6 | |
| PTQVQLRDVLLQLEA | 1011 | Q9NRC6 | |
| RARVLQQRQTIELIP | 321 | Q9Y2M2 | |
| QIPLQARELIDTILV | 501 | Q13490 | |
| IQVSRRLLSRPQDVL | 301 | Q5T9A4 | |
| RLLSRPQDVLEGVVL | 306 | Q5T9A4 | |
| QIDPTLRKHREQLVI | 941 | Q8N3C0 | |
| VIQLVRDPRAVLASR | 296 | Q7LGC8 | |
| ATRVQLVLPLLVAEA | 486 | Q9P2E5 | |
| AVEPDLLRSVLQQRL | 96 | Q6IPW1 | |
| ILNRSDIVEIPLELQ | 121 | Q9BXU1 | |
| IAREPLVRQVLRQTF | 596 | Q7KZ85 | |
| RQAVSLARRIQDPLI | 911 | Q7KZ85 | |
| LARRIQDPLIEFAQV | 916 | Q7KZ85 | |
| EILLQELEPVISRAV | 221 | Q5JU69 | |
| DVLLTQEVRPRQSKL | 86 | Q5VXH5 | |
| QEVRPRQSKLQVLDL | 91 | Q5VXH5 | |
| NRDQVLLAARELRVP | 91 | P10074 | |
| VVREVATRPLTQDLL | 266 | P09327 | |
| PSLEEAIRIASRIQQ | 616 | P52747 | |
| EPLLLQRSERVQTLE | 496 | Q5TAP6 | |
| PQQVALLDSLRVLTV | 2111 | Q8IZQ1 | |
| VHVEVRLLQRTDPNL | 436 | P60852 | |
| ELAPVRQQELASLLR | 606 | Q96AQ6 | |
| ALTERLALIQPSREQ | 61 | P78330 | |
| LALIQPSREQVQRLI | 66 | P78330 | |
| RLLQAPELETRVQAA | 131 | Q6SZW1 | |
| PELETRVQAARLLEQ | 136 | Q6SZW1 | |
| IFQAVVQRQPERLAL | 81 | Q6PCB7 | |
| VGSLEPRVEVLINRI | 46 | Q8N0S2 | |
| LVQLLVRGPASEREQ | 1156 | Q5XPI4 | |
| TVLTVIQAIRRDPEA | 681 | Q12788 | |
| LLQVPAQAVVRAVLE | 91 | Q8WWF5 | |
| LSTLIRQAIERQLPA | 606 | Q9Y2I1 | |
| LQEEILITRQRHIPD | 141 | Q8IYM1 | |
| LTPQVVSAARILLRN | 671 | P18206 | |
| RTSLEVPEINALLLV | 121 | Q86W42 | |
| VELQPLLTEISRTLN | 466 | Q12815 | |
| NPVLREVVDILTEQL | 91 | Q6H3X3 | |
| LIVESEAVRRQLLPQ | 176 | Q96DC7 | |
| EINPVRLSRLQGVER | 171 | Q9GZR1 | |
| TFLRRPINQVVLEEE | 226 | Q9HCK4 | |
| NPVLREVVDILTEQL | 91 | Q5VY80 | |
| LLQRPERVQTLEELE | 501 | Q9BVJ6 | |
| RVILENIASHEPRIQ | 836 | P02549 | |
| LTAEQLERELQLRPL | 166 | Q9NPB0 | |
| LLDPVRNRRLTVNEA | 2876 | Q15149 | |
| VVVLTNTPLEDQLRV | 161 | P22314 | |
| EVLEAVQRSLVLQRP | 686 | P22314 | |
| PVLEALVARAIRNIE | 626 | O75643 | |
| PRILNIKQRDTLVEN | 526 | Q9UJ78 | |
| IRVEEIIPAARVAIQ | 1306 | Q9UPU5 | |
| AQVSPELLLASVRRV | 416 | O43592 | |
| IAAPVEQLLVRTRSV | 336 | Q9ULD9 | |
| QIRELREVIELPLTN | 141 | P62333 | |
| VVELVQRAPEQLLAL | 1281 | A6NGW2 | |
| NPVLREVVDILTEQL | 91 | Q9BZM5 | |
| LQPQIDAITNDLRRI | 396 | Q8IY18 | |
| TSIQRIQRLIDSVPL | 516 | Q5T4S7 | |
| QERKNIRPNIILVLT | 36 | Q8IWU6 | |
| IRPNIILVLTDDQDV | 41 | Q8IWU6 | |
| PLTSAERELQQIRIN | 146 | Q6IBS0 | |
| EVRTLLQRSVQRLPA | 86 | Q562E7 | |
| IPESQIRQVIHLILE | 471 | P57678 | |
| TPRIQRLNELEAQTR | 66 | P41229 | |
| LQIDPTIQRVRAEER | 136 | O95678 | |
| VLLFANRIDIRQVLP | 441 | O75096 | |
| IRNVPLDEIDLLIQE | 231 | P53667 | |
| RSRQLLLTPNAVVIV | 936 | O00159 | |
| EQLNLLLREVIGRVV | 1051 | Q8WXR4 | |
| RQDVVRLLQLRTAEP | 1691 | Q13402 | |
| TSLLEEPNVIRVRNA | 4576 | P20929 | |
| RTQRLLRQLDAPVFV | 211 | Q14957 | |
| VLPRRAIEREEGQLQ | 916 | Q05586 |